Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tal1
|
ENSMUSG00000028717.6 | T cell acute lymphocytic leukemia 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_115059803_115061295 | Tal1 | 1041 | 0.468538 | 0.92 | 3.0e-25 | Click! |
chr4_115057577_115059724 | Tal1 | 839 | 0.556701 | 0.88 | 4.0e-20 | Click! |
chr4_115061778_115062015 | Tal1 | 2388 | 0.236623 | 0.87 | 4.0e-19 | Click! |
chr4_115048014_115048670 | Tal1 | 8084 | 0.155820 | 0.85 | 9.9e-18 | Click! |
chr4_115056183_115056334 | Tal1 | 168 | 0.940152 | 0.84 | 2.6e-17 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_127756656_127757307 | 42.38 |
Acmsd |
amino carboxymuconate semialdehyde decarboxylase |
224 |
0.93 |
chrX_8271051_8272966 | 42.25 |
Slc38a5 |
solute carrier family 38, member 5 |
366 |
0.82 |
chr8_84701273_84703379 | 40.60 |
Lyl1 |
lymphoblastomic leukemia 1 |
545 |
0.59 |
chr15_83169748_83171160 | 38.05 |
Cyb5r3 |
cytochrome b5 reductase 3 |
52 |
0.95 |
chr2_163356404_163356958 | 36.28 |
Tox2 |
TOX high mobility group box family member 2 |
36303 |
0.11 |
chrX_7966155_7966575 | 35.90 |
Gata1 |
GATA binding protein 1 |
1545 |
0.2 |
chr4_46040285_46040964 | 34.66 |
Tmod1 |
tropomodulin 1 |
1415 |
0.43 |
chr3_116563017_116563467 | 33.87 |
Lrrc39 |
leucine rich repeat containing 39 |
264 |
0.81 |
chr6_38341600_38342409 | 33.35 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
12269 |
0.13 |
chr4_154926952_154928851 | 32.14 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
176 |
0.92 |
chr9_105520039_105521535 | 31.57 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr11_102363631_102364272 | 31.38 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
247 |
0.85 |
chr13_45512026_45513101 | 30.07 |
Gmpr |
guanosine monophosphate reductase |
1277 |
0.51 |
chr4_40850475_40851213 | 29.94 |
Gm25931 |
predicted gene, 25931 |
442 |
0.43 |
chr11_84701121_84702313 | 29.93 |
1700109G15Rik |
RIKEN cDNA 1700109G15 gene |
18715 |
0.2 |
chr7_99824758_99826479 | 29.87 |
Neu3 |
neuraminidase 3 |
2799 |
0.17 |
chr6_136857054_136858156 | 29.58 |
Art4 |
ADP-ribosyltransferase 4 |
128 |
0.92 |
chr6_31612888_31614126 | 29.32 |
Gm43154 |
predicted gene 43154 |
8218 |
0.19 |
chr7_143005720_143007083 | 29.29 |
Tspan32 |
tetraspanin 32 |
473 |
0.68 |
chr15_73176794_73178055 | 28.85 |
Ago2 |
argonaute RISC catalytic subunit 2 |
423 |
0.85 |
chr15_44457385_44458529 | 28.36 |
Pkhd1l1 |
polycystic kidney and hepatic disease 1-like 1 |
404 |
0.83 |
chr15_97379421_97380753 | 27.26 |
Pced1b |
PC-esterase domain containing 1B |
18870 |
0.24 |
chr3_30765479_30765954 | 26.70 |
Samd7 |
sterile alpha motif domain containing 7 |
9494 |
0.14 |
chr13_109688282_109688550 | 26.56 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
2240 |
0.47 |
chr4_132075821_132077656 | 26.43 |
Epb41 |
erythrocyte membrane protein band 4.1 |
1417 |
0.25 |
chr14_70623688_70624289 | 26.30 |
Dmtn |
dematin actin binding protein |
2167 |
0.19 |
chr13_95671197_95671708 | 25.64 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
67 |
0.96 |
chr8_85379656_85380136 | 24.89 |
Mylk3 |
myosin light chain kinase 3 |
1082 |
0.42 |
chr17_45592643_45594205 | 24.88 |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
210 |
0.86 |
chr9_48338929_48340200 | 24.75 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
1270 |
0.48 |
chr6_101271529_101272523 | 24.62 |
9530086O07Rik |
RIKEN cDNA 9530086O07 gene |
16484 |
0.18 |
chr2_28620746_28622145 | 24.51 |
Gfi1b |
growth factor independent 1B |
500 |
0.68 |
chr4_134864478_134865098 | 24.51 |
Rhd |
Rh blood group, D antigen |
252 |
0.91 |
chr5_105409514_105410008 | 24.45 |
Gm32051 |
predicted gene, 32051 |
394 |
0.82 |
chr7_100494865_100496416 | 24.44 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
439 |
0.68 |
chr2_172348091_172348896 | 24.44 |
Fam210b |
family with sequence similarity 210, member B |
2928 |
0.18 |
chr5_74064229_74066220 | 23.86 |
Usp46 |
ubiquitin specific peptidase 46 |
524 |
0.65 |
chr19_6132290_6133043 | 23.86 |
Snx15 |
sorting nexin 15 |
4362 |
0.07 |
chr9_111055888_111057545 | 23.25 |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
530 |
0.62 |
chr7_80208732_80209894 | 23.23 |
Gm45206 |
predicted gene 45206 |
81 |
0.94 |
chr13_43235236_43235916 | 23.07 |
Tbc1d7 |
TBC1 domain family, member 7 |
64075 |
0.1 |
chr10_93143259_93144113 | 23.00 |
Cdk17 |
cyclin-dependent kinase 17 |
17189 |
0.17 |
chr16_90987984_90989157 | 22.86 |
Gm15965 |
predicted gene 15965 |
4663 |
0.12 |
chr12_111442182_111444685 | 22.79 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
771 |
0.51 |
chr6_67034247_67034846 | 22.50 |
E230016M11Rik |
RIKEN cDNA E230016M11 gene |
2053 |
0.19 |
chr17_25089311_25089630 | 22.39 |
Ift140 |
intraflagellar transport 140 |
1201 |
0.31 |
chr18_15345573_15345724 | 22.30 |
A830021F12Rik |
RIKEN cDNA A830021F12 gene |
6286 |
0.21 |
chrX_7968242_7968552 | 22.24 |
Gata1 |
GATA binding protein 1 |
487 |
0.61 |
chr14_63231019_63231782 | 22.22 |
Gata4 |
GATA binding protein 4 |
13848 |
0.16 |
chr9_24769617_24771807 | 22.17 |
Tbx20 |
T-box 20 |
962 |
0.56 |
chr4_100994515_100995079 | 22.00 |
Cachd1 |
cache domain containing 1 |
87 |
0.97 |
chr11_117781898_117782456 | 21.91 |
Tmc6 |
transmembrane channel-like gene family 6 |
21 |
0.57 |
chr17_40810971_40811398 | 21.73 |
Rhag |
Rhesus blood group-associated A glycoprotein |
0 |
0.97 |
chr11_116076531_116078496 | 21.69 |
Unc13d |
unc-13 homolog D |
77 |
0.94 |
chr14_70625458_70627688 | 21.62 |
Dmtn |
dematin actin binding protein |
418 |
0.75 |
chr14_55061871_55064122 | 21.57 |
Gm20687 |
predicted gene 20687 |
7503 |
0.08 |
chr8_23043503_23044627 | 21.42 |
Ank1 |
ankyrin 1, erythroid |
8834 |
0.18 |
chr19_31869464_31870017 | 21.39 |
A1cf |
APOBEC1 complementation factor |
959 |
0.64 |
chr13_38579867_38580777 | 21.33 |
Gm40922 |
predicted gene, 40922 |
25457 |
0.11 |
chr11_121239302_121240073 | 21.25 |
Narf |
nuclear prelamin A recognition factor |
2434 |
0.18 |
chr19_32238551_32238899 | 21.08 |
Sgms1 |
sphingomyelin synthase 1 |
87 |
0.98 |
chr4_32170638_32171072 | 21.00 |
Gm11928 |
predicted gene 11928 |
21069 |
0.18 |
chr10_69785224_69786670 | 20.98 |
Ank3 |
ankyrin 3, epithelial |
422 |
0.91 |
chr15_77754933_77755315 | 20.93 |
Apol8 |
apolipoprotein L 8 |
115 |
0.93 |
chr2_35334268_35334953 | 20.88 |
Stom |
stomatin |
2366 |
0.21 |
chr10_78004455_78005391 | 20.77 |
Pfkl |
phosphofructokinase, liver, B-type |
3444 |
0.14 |
chr17_29657893_29658263 | 20.67 |
Gm20161 |
predicted gene, 20161 |
258 |
0.85 |
chr9_21963175_21963912 | 20.58 |
Epor |
erythropoietin receptor |
37 |
0.94 |
chr1_120267677_120268469 | 20.52 |
Steap3 |
STEAP family member 3 |
2350 |
0.36 |
chr3_116389021_116389748 | 20.51 |
Cdc14a |
CDC14 cell division cycle 14A |
16104 |
0.15 |
chr14_27000422_27001594 | 20.40 |
Hesx1 |
homeobox gene expressed in ES cells |
646 |
0.71 |
chr8_122284632_122284861 | 20.26 |
Zfpm1 |
zinc finger protein, multitype 1 |
2605 |
0.23 |
chr1_82815577_82816643 | 20.25 |
Gm28942 |
predicted gene 28942 |
3725 |
0.11 |
chr13_95672253_95672993 | 20.24 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
1104 |
0.43 |
chrX_150550830_150551424 | 20.23 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
2910 |
0.2 |
chr4_153316698_153317280 | 20.19 |
Gm13174 |
predicted gene 13174 |
98813 |
0.08 |
chr9_21029266_21030734 | 20.14 |
Icam4 |
intercellular adhesion molecule 4, Landsteiner-Wiener blood group |
546 |
0.46 |
chr2_160326169_160327486 | 20.03 |
Gm826 |
predicted gene 826 |
667 |
0.78 |
chr17_63312183_63312970 | 19.97 |
4930405O22Rik |
RIKEN cDNA 4930405O22 gene |
395 |
0.87 |
chr16_92715410_92716513 | 19.93 |
Runx1 |
runt related transcription factor 1 |
18633 |
0.24 |
chr16_91804661_91805209 | 19.70 |
Itsn1 |
intersectin 1 (SH3 domain protein 1A) |
299 |
0.9 |
chr11_95340365_95340536 | 19.53 |
Fam117a |
family with sequence similarity 117, member A |
488 |
0.69 |
chr3_83008148_83008803 | 19.41 |
Gm30097 |
predicted gene, 30097 |
13 |
0.92 |
chr17_84776246_84777200 | 19.25 |
Lrpprc |
leucine-rich PPR-motif containing |
820 |
0.59 |
chr2_118887404_118888355 | 19.22 |
Ivd |
isovaleryl coenzyme A dehydrogenase |
11446 |
0.13 |
chr5_23922845_23923208 | 19.12 |
Fam126a |
family with sequence similarity 126, member A |
122 |
0.95 |
chr6_41701642_41702158 | 19.10 |
Kel |
Kell blood group |
2439 |
0.19 |
chr7_128854024_128855079 | 19.07 |
Gm25778 |
predicted gene, 25778 |
28204 |
0.15 |
chr5_137570868_137571950 | 19.03 |
Tfr2 |
transferrin receptor 2 |
42 |
0.93 |
chr15_38542701_38543715 | 18.88 |
Azin1 |
antizyme inhibitor 1 |
23942 |
0.1 |
chr2_105125289_105128976 | 18.87 |
Wt1 |
Wilms tumor 1 homolog |
78 |
0.91 |
chr8_33735092_33736026 | 18.82 |
Gtf2e2 |
general transcription factor II E, polypeptide 2 (beta subunit) |
2116 |
0.23 |
chr18_43736152_43737245 | 18.71 |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
859 |
0.6 |
chr11_11836398_11837549 | 18.56 |
Ddc |
dopa decarboxylase |
693 |
0.68 |
chr5_149648911_149649707 | 18.55 |
Gm20005 |
predicted gene, 20005 |
7699 |
0.14 |
chr17_86300838_86301701 | 18.54 |
2010106C02Rik |
RIKEN cDNA 2010106C02 gene |
14091 |
0.27 |
chr13_95535048_95536008 | 18.48 |
Gm48730 |
predicted gene, 48730 |
62 |
0.97 |
chr2_157026864_157027931 | 18.45 |
Soga1 |
suppressor of glucose, autophagy associated 1 |
75 |
0.96 |
chr7_75612178_75613652 | 18.41 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
631 |
0.75 |
chr1_74949307_74952042 | 18.39 |
Ihh |
Indian hedgehog |
768 |
0.5 |
chr14_66999338_66999780 | 18.35 |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
98 |
0.96 |
chr16_87705786_87706863 | 18.35 |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
7320 |
0.23 |
chr7_135721379_135721773 | 18.32 |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
5215 |
0.18 |
chr13_101691106_101693172 | 18.19 |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
204 |
0.95 |
chr8_122719956_122721464 | 18.09 |
C230057M02Rik |
RIKEN cDNA C230057M02 gene |
17801 |
0.09 |
chr1_173329069_173329645 | 18.00 |
Ackr1 |
atypical chemokine receptor 1 (Duffy blood group) |
4145 |
0.17 |
chr12_32123180_32123577 | 17.99 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
324 |
0.89 |
chr11_98580331_98580961 | 17.98 |
Ormdl3 |
ORM1-like 3 (S. cerevisiae) |
6722 |
0.11 |
chr19_17354797_17355050 | 17.95 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
1744 |
0.41 |
chr15_57888449_57889538 | 17.88 |
Derl1 |
Der1-like domain family, member 1 |
1401 |
0.45 |
chr11_32283784_32284776 | 17.83 |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
469 |
0.66 |
chr16_34031173_34031775 | 17.69 |
Kalrn |
kalirin, RhoGEF kinase |
14980 |
0.19 |
chr15_9074646_9075526 | 17.67 |
Nadk2 |
NAD kinase 2, mitochondrial |
191 |
0.96 |
chr1_173333573_173334024 | 17.63 |
Ackr1 |
atypical chemokine receptor 1 (Duffy blood group) |
48 |
0.97 |
chr11_109587022_109588156 | 17.57 |
Wipi1 |
WD repeat domain, phosphoinositide interacting 1 |
23843 |
0.13 |
chr13_83344494_83345147 | 17.51 |
Gm48156 |
predicted gene, 48156 |
155111 |
0.04 |
chr1_37478065_37479166 | 17.37 |
4930594C11Rik |
RIKEN cDNA 4930594C11 gene |
9990 |
0.14 |
chr1_136945385_136947968 | 17.32 |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
2497 |
0.34 |
chr11_116615789_116616584 | 17.32 |
Rhbdf2 |
rhomboid 5 homolog 2 |
8014 |
0.1 |
chr11_54026747_54027441 | 17.31 |
Slc22a4 |
solute carrier family 22 (organic cation transporter), member 4 |
858 |
0.54 |
chr6_117888079_117889227 | 17.30 |
Gm29509 |
predicted gene 29509 |
10548 |
0.11 |
chr3_86797975_86798459 | 17.21 |
Dclk2 |
doublecortin-like kinase 2 |
205 |
0.94 |
chr7_103812275_103812465 | 17.18 |
Hbb-bt |
hemoglobin, beta adult t chain |
1626 |
0.15 |
chr15_78260839_78261434 | 17.17 |
Ncf4 |
neutrophil cytosolic factor 4 |
258 |
0.88 |
chr17_40811481_40812037 | 17.07 |
Rhag |
Rhesus blood group-associated A glycoprotein |
575 |
0.7 |
chr7_103811249_103811813 | 17.06 |
Hbb-bt |
hemoglobin, beta adult t chain |
2465 |
0.1 |
chr13_97066853_97067365 | 16.91 |
Fam169a |
family with sequence similarity 169, member A |
177 |
0.94 |
chr14_25480994_25481876 | 16.88 |
Gm47921 |
predicted gene, 47921 |
1381 |
0.34 |
chr10_40140777_40141166 | 16.87 |
Slc16a10 |
solute carrier family 16 (monocarboxylic acid transporters), member 10 |
1283 |
0.36 |
chr3_104632268_104633005 | 16.80 |
Gm43582 |
predicted gene 43582 |
2021 |
0.18 |
chr13_41018072_41019454 | 16.70 |
Tmem14c |
transmembrane protein 14C |
2471 |
0.18 |
chr16_58672078_58672766 | 16.70 |
Cpox |
coproporphyrinogen oxidase |
1714 |
0.26 |
chr7_133700764_133701966 | 16.68 |
Uros |
uroporphyrinogen III synthase |
1173 |
0.35 |
chr2_38126201_38126464 | 16.57 |
Gm44291 |
predicted gene, 44291 |
19036 |
0.19 |
chr4_59533305_59533508 | 16.54 |
Gm12529 |
predicted gene 12529 |
659 |
0.67 |
chr8_70841499_70842327 | 16.53 |
Arrdc2 |
arrestin domain containing 2 |
2193 |
0.13 |
chr19_5842574_5845856 | 16.44 |
Neat1 |
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
1044 |
0.25 |
chr18_77704574_77705079 | 16.42 |
8030462N17Rik |
RIKEN cDNA 8030462N17 gene |
9107 |
0.14 |
chr7_102444287_102444743 | 16.37 |
Rrm1 |
ribonucleotide reductase M1 |
2472 |
0.15 |
chr10_86026040_86026657 | 16.36 |
A230060F14Rik |
RIKEN cDNA A230060F14 gene |
4019 |
0.13 |
chr4_93583349_93584162 | 16.32 |
Gm12640 |
predicted gene 12640 |
15431 |
0.19 |
chr11_97439854_97442222 | 16.25 |
Arhgap23 |
Rho GTPase activating protein 23 |
4753 |
0.18 |
chr14_76532606_76533942 | 16.25 |
E130202H07Rik |
RIKEN cDNA E130202H07 gene |
6658 |
0.2 |
chr4_137751465_137751943 | 16.20 |
Alpl |
alkaline phosphatase, liver/bone/kidney |
4557 |
0.21 |
chr8_68205432_68207408 | 16.13 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
363 |
0.91 |
chr11_32296600_32297646 | 16.10 |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
495 |
0.66 |
chr7_135809423_135810131 | 16.08 |
Gm36431 |
predicted gene, 36431 |
40187 |
0.12 |
chr11_96942052_96942604 | 16.07 |
Pnpo |
pyridoxine 5'-phosphate oxidase |
1451 |
0.2 |
chr16_90043846_90044623 | 16.06 |
Gm2805 |
predicted gene 2805 |
45749 |
0.15 |
chr19_46988462_46989023 | 16.05 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
19174 |
0.13 |
chr6_35254240_35255185 | 16.04 |
1810058I24Rik |
RIKEN cDNA 1810058I24 gene |
1980 |
0.27 |
chr8_80500537_80501246 | 16.03 |
Gypa |
glycophorin A |
7110 |
0.23 |
chr6_86666221_86666938 | 16.02 |
Gm44292 |
predicted gene, 44292 |
1028 |
0.35 |
chrX_7964296_7964600 | 16.01 |
Gata1 |
GATA binding protein 1 |
282 |
0.79 |
chr17_47909108_47910390 | 15.96 |
Gm15556 |
predicted gene 15556 |
12629 |
0.13 |
chr6_55336550_55338274 | 15.89 |
Aqp1 |
aquaporin 1 |
980 |
0.5 |
chr9_107489458_107490875 | 15.87 |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
15438 |
0.08 |
chr11_84822134_84823653 | 15.86 |
Mrm1 |
mitochondrial rRNA methyltransferase 1 |
3378 |
0.15 |
chr17_65605999_65606736 | 15.84 |
Vapa |
vesicle-associated membrane protein, associated protein A |
7188 |
0.17 |
chr9_64806162_64806616 | 15.84 |
Dennd4a |
DENN/MADD domain containing 4A |
4951 |
0.23 |
chr17_62748947_62749663 | 15.82 |
Efna5 |
ephrin A5 |
131839 |
0.06 |
chr1_88482217_88482931 | 15.81 |
Gm29538 |
predicted gene 29538 |
19966 |
0.14 |
chr7_18949615_18951696 | 15.78 |
Nova2 |
NOVA alternative splicing regulator 2 |
24767 |
0.07 |
chr12_69757617_69759559 | 15.71 |
Mir681 |
microRNA 681 |
5356 |
0.14 |
chr5_33529197_33530303 | 15.68 |
Gm43851 |
predicted gene 43851 |
92286 |
0.05 |
chr15_76666348_76670076 | 15.66 |
Foxh1 |
forkhead box H1 |
1590 |
0.15 |
chr6_83246352_83246636 | 15.66 |
Slc4a5 |
solute carrier family 4, sodium bicarbonate cotransporter, member 5 |
9119 |
0.12 |
chr3_137968340_137969523 | 15.65 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
12599 |
0.12 |
chr2_155989437_155990012 | 15.65 |
Cep250 |
centrosomal protein 250 |
3809 |
0.13 |
chr13_93239462_93239901 | 15.63 |
Tent2 |
terminal nucleotidyltransferase 2 |
47296 |
0.11 |
chr17_24202438_24203465 | 15.59 |
Tbc1d24 |
TBC1 domain family, member 24 |
2531 |
0.12 |
chr3_146392721_146394033 | 15.56 |
Gm22078 |
predicted gene, 22078 |
5533 |
0.14 |
chr19_27905991_27906247 | 15.54 |
Rfx3 |
regulatory factor X, 3 (influences HLA class II expression) |
5224 |
0.27 |
chr8_94985246_94986199 | 15.54 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
154 |
0.93 |
chr11_101449130_101449504 | 15.48 |
Ifi35 |
interferon-induced protein 35 |
747 |
0.35 |
chr6_58642449_58642948 | 15.48 |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
2116 |
0.36 |
chr9_48814519_48815058 | 15.48 |
Zbtb16 |
zinc finger and BTB domain containing 16 |
21157 |
0.22 |
chr17_15084011_15084916 | 15.46 |
Ermard |
ER membrane associated RNA degradation |
18848 |
0.15 |
chr16_38350357_38350982 | 15.46 |
Cox17 |
cytochrome c oxidase assembly protein 17, copper chaperone |
1377 |
0.29 |
chr7_120173917_120175138 | 15.38 |
Anks4b |
ankyrin repeat and sterile alpha motif domain containing 4B |
669 |
0.61 |
chr7_123462181_123462933 | 15.38 |
Aqp8 |
aquaporin 8 |
245 |
0.93 |
chr5_64810297_64813272 | 15.38 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
chr12_83072442_83073418 | 15.36 |
Rgs6 |
regulator of G-protein signaling 6 |
25940 |
0.15 |
chr3_122247075_122247647 | 15.35 |
Gclm |
glutamate-cysteine ligase, modifier subunit |
1280 |
0.26 |
chr3_83026692_83027527 | 15.31 |
Fga |
fibrinogen alpha chain |
894 |
0.5 |
chr17_71204583_71205351 | 15.29 |
Lpin2 |
lipin 2 |
291 |
0.89 |
chr12_76673565_76674554 | 15.28 |
Sptb |
spectrin beta, erythrocytic |
35964 |
0.15 |
chr12_76709116_76709328 | 15.27 |
Sptb |
spectrin beta, erythrocytic |
801 |
0.65 |
chr12_84150828_84152588 | 15.25 |
Pnma1 |
paraneoplastic antigen MA1 |
3219 |
0.13 |
chr8_111595671_111596310 | 15.22 |
Znrf1 |
zinc and ring finger 1 |
10758 |
0.17 |
chr8_34096835_34098006 | 15.22 |
Dctn6 |
dynactin 6 |
271 |
0.85 |
chr14_63244119_63245953 | 15.18 |
Gata4 |
GATA binding protein 4 |
212 |
0.93 |
chr1_181334992_181336043 | 15.11 |
Cnih3 |
cornichon family AMPA receptor auxiliary protein 3 |
17111 |
0.15 |
chr14_63062151_63062451 | 15.07 |
Defb42 |
defensin beta 42 |
7228 |
0.12 |
chr16_12697496_12698095 | 15.03 |
Gm38619 |
predicted gene, 38619 |
6573 |
0.28 |
chr2_32127772_32128677 | 15.01 |
Prrc2b |
proline-rich coiled-coil 2B |
22858 |
0.1 |
chr18_32557788_32558922 | 15.00 |
Gypc |
glycophorin C |
1625 |
0.41 |
chr7_103909977_103910867 | 14.98 |
Olfr65 |
olfactory receptor 65 |
4080 |
0.08 |
chr19_6284307_6284998 | 14.95 |
Ehd1 |
EH-domain containing 1 |
7727 |
0.07 |
chr8_122283791_122284605 | 14.91 |
Zfpm1 |
zinc finger protein, multitype 1 |
2057 |
0.27 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.0 | 71.9 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
14.9 | 74.3 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
14.4 | 14.4 | GO:0048769 | sarcomerogenesis(GO:0048769) |
11.5 | 23.0 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
11.1 | 11.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
11.1 | 44.4 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
10.5 | 41.8 | GO:0003175 | tricuspid valve development(GO:0003175) |
9.8 | 29.4 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
9.3 | 9.3 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
9.0 | 26.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
8.2 | 24.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
8.0 | 32.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
8.0 | 15.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
7.9 | 23.6 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
7.7 | 23.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
7.4 | 22.3 | GO:0002432 | granuloma formation(GO:0002432) |
7.3 | 21.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
7.2 | 21.6 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
7.2 | 21.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
7.0 | 28.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
7.0 | 20.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
6.8 | 27.2 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
6.8 | 20.3 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
6.7 | 20.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
6.6 | 39.6 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
6.6 | 19.7 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
6.4 | 51.5 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
6.3 | 50.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
6.2 | 18.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
5.9 | 47.0 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
5.7 | 17.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
5.7 | 17.1 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
5.7 | 22.8 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
5.7 | 28.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
5.6 | 139.3 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
5.6 | 16.7 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
5.3 | 15.9 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
5.3 | 5.3 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
5.3 | 21.1 | GO:0070836 | caveola assembly(GO:0070836) |
5.1 | 20.5 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
4.9 | 14.8 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
4.8 | 33.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
4.7 | 14.2 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
4.7 | 4.7 | GO:0018992 | germ-line sex determination(GO:0018992) |
4.6 | 13.9 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
4.5 | 13.6 | GO:0008228 | opsonization(GO:0008228) |
4.5 | 18.0 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
4.4 | 17.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
4.4 | 21.9 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
4.4 | 8.7 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
4.4 | 4.4 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
4.4 | 21.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
4.2 | 16.7 | GO:0097286 | iron ion import(GO:0097286) |
4.1 | 4.1 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
4.1 | 20.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
4.0 | 20.1 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
4.0 | 19.9 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
4.0 | 11.9 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
3.9 | 3.9 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
3.9 | 15.5 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
3.9 | 19.4 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
3.8 | 3.8 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
3.7 | 11.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
3.7 | 7.4 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
3.7 | 11.0 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
3.7 | 14.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
3.6 | 10.9 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
3.6 | 21.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
3.6 | 7.2 | GO:0015684 | ferrous iron transport(GO:0015684) |
3.6 | 7.1 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
3.6 | 10.7 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
3.5 | 10.6 | GO:0070488 | neutrophil aggregation(GO:0070488) |
3.5 | 14.1 | GO:0032264 | IMP salvage(GO:0032264) |
3.5 | 14.0 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
3.5 | 55.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
3.5 | 31.2 | GO:0070269 | pyroptosis(GO:0070269) |
3.4 | 34.4 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
3.4 | 13.8 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
3.4 | 3.4 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
3.3 | 13.4 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
3.3 | 13.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
3.3 | 9.9 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
3.3 | 23.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
3.3 | 16.3 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
3.3 | 16.3 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
3.3 | 9.8 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
3.2 | 22.7 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
3.2 | 58.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
3.2 | 32.3 | GO:0015816 | glycine transport(GO:0015816) |
3.2 | 9.7 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
3.1 | 9.4 | GO:0015886 | heme transport(GO:0015886) |
3.1 | 9.4 | GO:0018343 | protein farnesylation(GO:0018343) |
3.1 | 15.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
3.1 | 6.2 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
3.1 | 9.2 | GO:0042117 | monocyte activation(GO:0042117) |
3.1 | 6.1 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
3.0 | 15.2 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
3.0 | 21.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
3.0 | 21.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
3.0 | 8.9 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
3.0 | 5.9 | GO:0071316 | cellular response to nicotine(GO:0071316) |
3.0 | 8.9 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
2.9 | 2.9 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
2.9 | 5.8 | GO:0006059 | hexitol metabolic process(GO:0006059) |
2.9 | 5.7 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
2.9 | 8.6 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
2.8 | 8.5 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
2.8 | 8.5 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
2.8 | 11.4 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
2.8 | 11.4 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
2.8 | 5.6 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
2.8 | 25.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
2.8 | 50.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
2.8 | 8.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
2.8 | 8.3 | GO:0061010 | gall bladder development(GO:0061010) |
2.8 | 16.6 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
2.8 | 5.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
2.7 | 11.0 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
2.7 | 13.7 | GO:0015879 | carnitine transport(GO:0015879) |
2.7 | 10.9 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
2.7 | 5.5 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
2.7 | 5.4 | GO:0043173 | nucleotide salvage(GO:0043173) |
2.7 | 8.2 | GO:0035483 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
2.7 | 2.7 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
2.7 | 10.8 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
2.7 | 8.1 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
2.7 | 2.7 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
2.7 | 16.0 | GO:0045332 | phospholipid translocation(GO:0045332) |
2.7 | 2.7 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
2.7 | 13.3 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
2.7 | 2.7 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
2.6 | 15.9 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
2.6 | 7.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
2.6 | 10.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
2.6 | 5.2 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
2.6 | 7.8 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
2.6 | 10.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
2.6 | 7.7 | GO:0015677 | copper ion import(GO:0015677) |
2.6 | 7.7 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
2.5 | 2.5 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
2.5 | 10.0 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
2.5 | 14.9 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
2.5 | 7.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
2.4 | 7.3 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
2.4 | 7.3 | GO:0035973 | aggrephagy(GO:0035973) |
2.4 | 2.4 | GO:0048382 | mesendoderm development(GO:0048382) |
2.4 | 4.9 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
2.4 | 19.3 | GO:0006000 | fructose metabolic process(GO:0006000) |
2.4 | 7.2 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
2.4 | 12.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.4 | 45.3 | GO:0048821 | erythrocyte development(GO:0048821) |
2.4 | 2.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
2.3 | 4.7 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.3 | 32.5 | GO:0006828 | manganese ion transport(GO:0006828) |
2.3 | 13.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
2.3 | 13.8 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
2.3 | 6.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
2.3 | 4.6 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
2.3 | 4.5 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
2.3 | 15.9 | GO:0071318 | cellular response to ATP(GO:0071318) |
2.3 | 4.5 | GO:0070669 | response to interleukin-2(GO:0070669) |
2.3 | 6.8 | GO:0035754 | B cell chemotaxis(GO:0035754) |
2.3 | 4.5 | GO:0036394 | amylase secretion(GO:0036394) |
2.3 | 4.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
2.3 | 11.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
2.3 | 6.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
2.2 | 2.2 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
2.2 | 4.5 | GO:1901678 | iron coordination entity transport(GO:1901678) |
2.2 | 26.8 | GO:0051601 | exocyst localization(GO:0051601) |
2.2 | 6.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
2.2 | 4.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
2.2 | 4.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.2 | 19.7 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
2.2 | 17.4 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
2.2 | 8.7 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
2.2 | 6.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.2 | 2.2 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
2.1 | 2.1 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
2.1 | 23.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
2.1 | 8.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
2.1 | 4.3 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
2.1 | 8.5 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
2.1 | 4.2 | GO:0046618 | drug export(GO:0046618) |
2.1 | 16.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
2.1 | 4.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
2.1 | 4.2 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
2.1 | 14.6 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
2.1 | 2.1 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
2.1 | 14.5 | GO:0015825 | L-serine transport(GO:0015825) |
2.1 | 6.2 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
2.1 | 4.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
2.1 | 2.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
2.1 | 10.3 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
2.0 | 6.1 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
2.0 | 22.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
2.0 | 2.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
2.0 | 2.0 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
2.0 | 10.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
2.0 | 6.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
2.0 | 6.0 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
2.0 | 8.0 | GO:0033194 | response to hydroperoxide(GO:0033194) |
2.0 | 5.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
2.0 | 4.0 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
2.0 | 5.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
2.0 | 3.9 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
2.0 | 3.9 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
1.9 | 1.9 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
1.9 | 7.7 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.9 | 5.8 | GO:0006562 | proline catabolic process(GO:0006562) |
1.9 | 5.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.9 | 11.4 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
1.9 | 3.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.9 | 16.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.9 | 13.1 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
1.9 | 1.9 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.9 | 18.6 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
1.9 | 11.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.9 | 3.7 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
1.9 | 16.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.9 | 3.7 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.8 | 5.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.8 | 1.8 | GO:0097066 | response to thyroid hormone(GO:0097066) |
1.8 | 5.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.8 | 34.7 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.8 | 10.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.8 | 1.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) mitotic DNA replication(GO:1902969) |
1.8 | 5.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.8 | 9.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
1.8 | 3.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.8 | 8.9 | GO:1904970 | brush border assembly(GO:1904970) |
1.8 | 5.4 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
1.8 | 3.6 | GO:0072275 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
1.8 | 12.5 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
1.7 | 10.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.7 | 8.7 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.7 | 38.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
1.7 | 1.7 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
1.7 | 5.2 | GO:0009838 | abscission(GO:0009838) |
1.7 | 1.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
1.7 | 3.5 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
1.7 | 12.0 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
1.7 | 15.4 | GO:0001865 | NK T cell differentiation(GO:0001865) |
1.7 | 15.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.7 | 17.0 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
1.7 | 15.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.7 | 1.7 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.7 | 8.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.7 | 13.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
1.7 | 5.0 | GO:0000087 | mitotic M phase(GO:0000087) |
1.7 | 5.0 | GO:0036258 | multivesicular body assembly(GO:0036258) |
1.7 | 18.4 | GO:0015858 | nucleoside transport(GO:0015858) |
1.7 | 1.7 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.7 | 5.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
1.7 | 5.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
1.7 | 5.0 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
1.7 | 6.6 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
1.7 | 1.7 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.6 | 1.6 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
1.6 | 3.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.6 | 16.4 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
1.6 | 62.3 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
1.6 | 9.8 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
1.6 | 6.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.6 | 8.1 | GO:0001842 | neural fold formation(GO:0001842) |
1.6 | 4.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
1.6 | 13.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
1.6 | 1.6 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
1.6 | 33.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
1.6 | 3.2 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
1.6 | 1.6 | GO:0032782 | bile acid secretion(GO:0032782) |
1.6 | 6.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
1.6 | 8.0 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.6 | 11.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.6 | 6.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.6 | 19.1 | GO:0072520 | seminiferous tubule development(GO:0072520) |
1.6 | 3.2 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
1.6 | 12.7 | GO:0002467 | germinal center formation(GO:0002467) |
1.6 | 4.7 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.6 | 17.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.6 | 6.3 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
1.6 | 4.7 | GO:0015705 | iodide transport(GO:0015705) |
1.6 | 9.4 | GO:0060613 | fat pad development(GO:0060613) |
1.6 | 3.1 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
1.6 | 3.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.6 | 7.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
1.6 | 6.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
1.6 | 6.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.6 | 6.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.5 | 3.1 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
1.5 | 6.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
1.5 | 3.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
1.5 | 6.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
1.5 | 1.5 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
1.5 | 4.6 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
1.5 | 10.7 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
1.5 | 3.0 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
1.5 | 1.5 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
1.5 | 4.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
1.5 | 7.5 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.5 | 10.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.5 | 7.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.5 | 4.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.5 | 1.5 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
1.5 | 7.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
1.5 | 2.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.5 | 2.9 | GO:0043379 | memory T cell differentiation(GO:0043379) |
1.5 | 4.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
1.5 | 1.5 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.5 | 1.5 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
1.5 | 2.9 | GO:0032202 | telomere assembly(GO:0032202) |
1.5 | 4.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.5 | 7.3 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
1.4 | 4.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.4 | 5.8 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.4 | 4.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
1.4 | 1.4 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
1.4 | 2.9 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
1.4 | 4.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.4 | 4.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
1.4 | 4.3 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.4 | 2.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.4 | 1.4 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.4 | 2.8 | GO:0046104 | thymidine metabolic process(GO:0046104) |
1.4 | 1.4 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
1.4 | 4.2 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
1.4 | 2.8 | GO:0061511 | centriole elongation(GO:0061511) |
1.4 | 7.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.4 | 1.4 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
1.4 | 5.5 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
1.4 | 2.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.4 | 2.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.4 | 9.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
1.4 | 5.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.4 | 9.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.3 | 1.3 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
1.3 | 4.0 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.3 | 14.7 | GO:0070828 | heterochromatin organization(GO:0070828) |
1.3 | 6.7 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
1.3 | 10.7 | GO:0042730 | fibrinolysis(GO:0042730) |
1.3 | 2.7 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
1.3 | 29.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
1.3 | 1.3 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
1.3 | 1.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
1.3 | 5.3 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
1.3 | 5.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
1.3 | 14.5 | GO:0032801 | receptor catabolic process(GO:0032801) |
1.3 | 17.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
1.3 | 1.3 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
1.3 | 20.9 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
1.3 | 1.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
1.3 | 23.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
1.3 | 3.9 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.3 | 10.4 | GO:0070307 | lens fiber cell development(GO:0070307) |
1.3 | 2.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
1.3 | 5.2 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.3 | 2.6 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
1.3 | 7.7 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
1.3 | 3.9 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
1.3 | 3.9 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.3 | 15.4 | GO:0000305 | response to oxygen radical(GO:0000305) |
1.3 | 2.6 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
1.3 | 7.6 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.3 | 6.3 | GO:0015671 | oxygen transport(GO:0015671) |
1.3 | 1.3 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
1.3 | 7.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.3 | 3.8 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.3 | 3.8 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
1.2 | 1.2 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
1.2 | 5.0 | GO:0009642 | response to light intensity(GO:0009642) |
1.2 | 2.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.2 | 1.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.2 | 2.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.2 | 3.7 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
1.2 | 6.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.2 | 1.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.2 | 11.0 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
1.2 | 21.8 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
1.2 | 4.8 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
1.2 | 8.5 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
1.2 | 3.6 | GO:0009804 | coumarin metabolic process(GO:0009804) |
1.2 | 1.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.2 | 1.2 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.2 | 4.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.2 | 3.6 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
1.2 | 3.6 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.2 | 1.2 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
1.2 | 2.4 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
1.2 | 3.6 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
1.2 | 2.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.2 | 3.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.2 | 11.9 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.2 | 14.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
1.2 | 4.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.2 | 11.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.2 | 1.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
1.2 | 4.7 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
1.2 | 39.8 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
1.2 | 3.5 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
1.2 | 5.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
1.2 | 1.2 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
1.2 | 8.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.2 | 26.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
1.1 | 2.3 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
1.1 | 2.3 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
1.1 | 8.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.1 | 6.8 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.1 | 5.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.1 | 3.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.1 | 6.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.1 | 6.7 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.1 | 3.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.1 | 4.5 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
1.1 | 3.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.1 | 7.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.1 | 6.7 | GO:0046415 | urate metabolic process(GO:0046415) |
1.1 | 11.1 | GO:0001675 | acrosome assembly(GO:0001675) |
1.1 | 1.1 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
1.1 | 12.2 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
1.1 | 3.3 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.1 | 1.1 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
1.1 | 2.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
1.1 | 4.4 | GO:0019532 | oxalate transport(GO:0019532) |
1.1 | 1.1 | GO:0019042 | viral latency(GO:0019042) |
1.1 | 2.2 | GO:0022615 | protein to membrane docking(GO:0022615) |
1.1 | 5.4 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
1.1 | 2.1 | GO:0030421 | defecation(GO:0030421) |
1.1 | 5.4 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.1 | 4.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.1 | 2.1 | GO:0002215 | defense response to nematode(GO:0002215) |
1.1 | 4.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
1.1 | 3.2 | GO:0071047 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
1.1 | 3.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.1 | 2.1 | GO:0072672 | neutrophil extravasation(GO:0072672) |
1.1 | 5.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
1.1 | 4.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.0 | 1.0 | GO:0048143 | astrocyte activation(GO:0048143) |
1.0 | 2.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.0 | 8.4 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
1.0 | 2.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
1.0 | 5.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.0 | 3.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.0 | 2.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.0 | 1.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.0 | 1.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.0 | 5.2 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
1.0 | 4.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
1.0 | 1.0 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
1.0 | 4.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
1.0 | 3.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.0 | 9.2 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
1.0 | 1.0 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
1.0 | 4.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
1.0 | 3.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
1.0 | 2.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
1.0 | 8.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.0 | 2.0 | GO:0070375 | ERK5 cascade(GO:0070375) |
1.0 | 1.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
1.0 | 3.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.0 | 4.0 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.0 | 9.0 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
1.0 | 3.0 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
1.0 | 4.0 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.0 | 4.9 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
1.0 | 3.0 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.0 | 4.9 | GO:0015871 | choline transport(GO:0015871) |
1.0 | 1.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
1.0 | 2.9 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
1.0 | 2.9 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.0 | 5.9 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
1.0 | 2.9 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.0 | 2.9 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
1.0 | 2.9 | GO:0006116 | NADH oxidation(GO:0006116) |
1.0 | 1.0 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
1.0 | 1.9 | GO:0003161 | cardiac conduction system development(GO:0003161) |
1.0 | 2.9 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.0 | 5.8 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
1.0 | 7.8 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
1.0 | 2.9 | GO:0001880 | Mullerian duct regression(GO:0001880) |
1.0 | 4.8 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
1.0 | 1.9 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
1.0 | 1.0 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
1.0 | 1.9 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
1.0 | 3.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.0 | 7.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
1.0 | 3.8 | GO:0007296 | vitellogenesis(GO:0007296) |
1.0 | 1.0 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
1.0 | 3.8 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
1.0 | 1.0 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
1.0 | 1.0 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
1.0 | 1.0 | GO:0042851 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.9 | 1.9 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.9 | 5.7 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.9 | 1.9 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.9 | 3.8 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.9 | 6.6 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.9 | 1.9 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.9 | 0.9 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.9 | 0.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.9 | 3.7 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.9 | 0.9 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.9 | 10.2 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.9 | 13.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.9 | 5.6 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.9 | 4.6 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.9 | 4.6 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.9 | 1.8 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.9 | 6.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.9 | 2.8 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.9 | 1.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.9 | 1.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.9 | 2.7 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.9 | 14.6 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.9 | 0.9 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.9 | 2.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.9 | 1.8 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.9 | 3.6 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.9 | 5.4 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.9 | 0.9 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.9 | 1.8 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.9 | 10.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.9 | 17.1 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.9 | 2.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.9 | 3.6 | GO:0042168 | heme metabolic process(GO:0042168) |
0.9 | 9.8 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.9 | 12.5 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.9 | 4.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.9 | 3.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.9 | 1.8 | GO:1903416 | response to glycoside(GO:1903416) |
0.9 | 1.8 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.9 | 2.7 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.9 | 1.8 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.9 | 1.8 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.9 | 2.6 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.9 | 1.8 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.9 | 7.0 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.9 | 6.1 | GO:0007343 | egg activation(GO:0007343) |
0.9 | 0.9 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.9 | 0.9 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.9 | 7.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.9 | 3.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.9 | 1.7 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.9 | 0.9 | GO:0043467 | regulation of generation of precursor metabolites and energy(GO:0043467) |
0.9 | 9.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.9 | 2.6 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.9 | 1.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.9 | 1.7 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.9 | 1.7 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.9 | 0.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.9 | 3.4 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.9 | 0.9 | GO:0008050 | female courtship behavior(GO:0008050) |
0.9 | 3.4 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.9 | 2.6 | GO:0030575 | nuclear body organization(GO:0030575) |
0.9 | 0.9 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.9 | 2.6 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.9 | 3.4 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.9 | 1.7 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.8 | 13.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.8 | 5.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.8 | 0.8 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.8 | 5.9 | GO:0006265 | DNA topological change(GO:0006265) |
0.8 | 1.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.8 | 2.5 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.8 | 5.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.8 | 14.9 | GO:0030488 | tRNA methylation(GO:0030488) |
0.8 | 4.9 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.8 | 4.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.8 | 3.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.8 | 2.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.8 | 6.5 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.8 | 2.4 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.8 | 1.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.8 | 0.8 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.8 | 2.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.8 | 4.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.8 | 6.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.8 | 0.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.8 | 4.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.8 | 2.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.8 | 11.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.8 | 3.2 | GO:0070293 | renal absorption(GO:0070293) |
0.8 | 2.4 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.8 | 5.6 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.8 | 8.8 | GO:0031167 | rRNA methylation(GO:0031167) |
0.8 | 1.6 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.8 | 1.6 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.8 | 2.4 | GO:0015817 | histidine transport(GO:0015817) |
0.8 | 2.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.8 | 3.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.8 | 3.9 | GO:0051013 | microtubule severing(GO:0051013) |
0.8 | 18.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.8 | 3.1 | GO:0039531 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039531) |
0.8 | 2.4 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.8 | 1.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.8 | 2.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.8 | 3.9 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.8 | 2.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.8 | 0.8 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
0.8 | 1.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.8 | 2.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.8 | 2.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.8 | 3.1 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.8 | 3.1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.8 | 3.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.8 | 0.8 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.8 | 1.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.8 | 3.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.8 | 3.9 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.8 | 3.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.8 | 12.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.8 | 7.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.8 | 2.3 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.8 | 5.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.8 | 2.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.8 | 2.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.8 | 3.0 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.8 | 11.3 | GO:0002021 | response to dietary excess(GO:0002021) |
0.8 | 2.3 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.8 | 7.5 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.7 | 0.7 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.7 | 0.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.7 | 12.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.7 | 1.5 | GO:0032439 | endosome localization(GO:0032439) |
0.7 | 0.7 | GO:0050832 | defense response to fungus(GO:0050832) |
0.7 | 2.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.7 | 3.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.7 | 3.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.7 | 3.0 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.7 | 1.5 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.7 | 2.9 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.7 | 10.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.7 | 0.7 | GO:0032252 | secretory granule localization(GO:0032252) |
0.7 | 0.7 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.7 | 2.9 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.7 | 2.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.7 | 3.6 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.7 | 1.4 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.7 | 10.1 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.7 | 1.4 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.7 | 2.2 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.7 | 1.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.7 | 1.4 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.7 | 5.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.7 | 5.0 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.7 | 2.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.7 | 7.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.7 | 4.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.7 | 1.4 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.7 | 4.9 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.7 | 5.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.7 | 2.1 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.7 | 2.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.7 | 6.9 | GO:0051304 | chromosome separation(GO:0051304) |
0.7 | 4.1 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.7 | 0.7 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.7 | 3.4 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.7 | 0.7 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.7 | 0.7 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.7 | 0.7 | GO:0072718 | response to cisplatin(GO:0072718) |
0.7 | 6.8 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.7 | 0.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.7 | 0.7 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.7 | 7.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.7 | 4.0 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.7 | 17.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.7 | 2.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.7 | 0.7 | GO:0043366 | beta selection(GO:0043366) |
0.7 | 1.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.7 | 3.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.7 | 0.7 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.7 | 7.4 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.7 | 28.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.7 | 10.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.7 | 0.7 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.7 | 0.7 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.7 | 0.7 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.7 | 0.7 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.7 | 4.0 | GO:0031297 | replication fork processing(GO:0031297) |
0.7 | 6.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.7 | 0.7 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.7 | 0.7 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.7 | 1.3 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.7 | 5.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.7 | 2.0 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.7 | 2.6 | GO:0072431 | signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.7 | 1.3 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.7 | 3.9 | GO:0006959 | humoral immune response(GO:0006959) |
0.7 | 3.9 | GO:0016556 | mRNA modification(GO:0016556) |
0.7 | 0.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.7 | 2.6 | GO:0015074 | DNA integration(GO:0015074) |
0.6 | 14.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.6 | 8.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.6 | 1.9 | GO:1901679 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.6 | 0.6 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.6 | 1.3 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.6 | 0.6 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.6 | 1.3 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.6 | 4.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.6 | 1.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.6 | 3.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.6 | 1.3 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.6 | 1.3 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.6 | 0.6 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.6 | 16.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.6 | 0.6 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.6 | 0.6 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.6 | 0.6 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.6 | 0.6 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.6 | 1.3 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.6 | 0.6 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.6 | 1.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.6 | 0.6 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.6 | 5.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.6 | 3.7 | GO:0009299 | mRNA transcription(GO:0009299) |
0.6 | 5.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.6 | 2.5 | GO:0052803 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound metabolic process(GO:0052803) imidazole-containing compound catabolic process(GO:0052805) |
0.6 | 5.0 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.6 | 1.9 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.6 | 2.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.6 | 12.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.6 | 1.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.6 | 3.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.6 | 0.6 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
0.6 | 1.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.6 | 4.3 | GO:1902624 | positive regulation of neutrophil migration(GO:1902624) |
0.6 | 16.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.6 | 31.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.6 | 11.0 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.6 | 0.6 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.6 | 1.2 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.6 | 4.9 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.6 | 7.9 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.6 | 1.2 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.6 | 4.3 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.6 | 3.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.6 | 1.8 | GO:0007525 | somatic muscle development(GO:0007525) |
0.6 | 1.2 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.6 | 1.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.6 | 3.6 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.6 | 0.6 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.6 | 4.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.6 | 1.8 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.6 | 4.7 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.6 | 2.4 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.6 | 3.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.6 | 1.2 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.6 | 0.6 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
0.6 | 2.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.6 | 1.8 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.6 | 1.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.6 | 1.8 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.6 | 2.9 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.6 | 1.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.6 | 0.6 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.6 | 1.7 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.6 | 1.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.6 | 1.7 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.6 | 23.6 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.6 | 4.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.6 | 2.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.6 | 2.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.6 | 0.6 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.6 | 6.9 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.6 | 8.0 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.6 | 3.4 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.6 | 1.7 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.6 | 7.9 | GO:0017144 | drug metabolic process(GO:0017144) |
0.6 | 1.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.6 | 0.6 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.6 | 0.6 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.6 | 9.6 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.6 | 1.1 | GO:1990774 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.6 | 3.9 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.6 | 1.7 | GO:0034405 | response to fluid shear stress(GO:0034405) cellular response to fluid shear stress(GO:0071498) |
0.6 | 1.7 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.6 | 2.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.6 | 1.7 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.6 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.6 | 1.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.6 | 0.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.6 | 0.6 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.6 | 1.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.5 | 0.5 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) |
0.5 | 1.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.5 | 1.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.5 | 1.1 | GO:0045979 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.5 | 0.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.5 | 2.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.5 | 0.5 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.5 | 5.9 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.5 | 0.5 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.5 | 3.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.5 | 3.7 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.5 | 1.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.5 | 3.7 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.5 | 3.2 | GO:0006560 | proline metabolic process(GO:0006560) |
0.5 | 9.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.5 | 3.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.5 | 1.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.5 | 2.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.5 | 1.1 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.5 | 1.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.5 | 0.5 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.5 | 1.1 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.5 | 0.5 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.5 | 0.5 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.5 | 12.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.5 | 33.0 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.5 | 4.2 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.5 | 2.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.5 | 1.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.5 | 2.6 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.5 | 5.7 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.5 | 5.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.5 | 7.2 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.5 | 3.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.5 | 0.5 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.5 | 6.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.5 | 0.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.5 | 3.1 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.5 | 1.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.5 | 7.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.5 | 1.0 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.5 | 5.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.5 | 0.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.5 | 0.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.5 | 1.5 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.5 | 7.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.5 | 1.0 | GO:1902075 | cellular response to salt(GO:1902075) |
0.5 | 1.0 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.5 | 1.5 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.5 | 5.5 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.5 | 6.0 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.5 | 0.5 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.5 | 1.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.5 | 0.5 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.5 | 1.0 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.5 | 0.5 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.5 | 9.9 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.5 | 3.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.5 | 3.0 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.5 | 3.9 | GO:0042407 | cristae formation(GO:0042407) |
0.5 | 0.5 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.5 | 2.9 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.5 | 3.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.5 | 7.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.5 | 3.4 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.5 | 8.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.5 | 0.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.5 | 0.5 | GO:0034204 | lipid translocation(GO:0034204) |
0.5 | 1.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.5 | 0.5 | GO:0021564 | vagus nerve development(GO:0021564) |
0.5 | 0.5 | GO:0070459 | prolactin secretion(GO:0070459) |
0.5 | 1.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.5 | 1.9 | GO:0090383 | phagosome acidification(GO:0090383) |
0.5 | 1.4 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.5 | 1.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.5 | 0.5 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.5 | 1.0 | GO:1904705 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.5 | 2.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 0.5 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.5 | 2.8 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.5 | 0.9 | GO:0015884 | folic acid transport(GO:0015884) |
0.5 | 4.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.5 | 1.4 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.5 | 5.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.5 | 2.4 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.5 | 0.5 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.5 | 2.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.5 | 0.5 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.5 | 7.0 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.5 | 0.5 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.5 | 0.9 | GO:0032098 | regulation of appetite(GO:0032098) |
0.5 | 1.9 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.5 | 1.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.5 | 9.7 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.5 | 12.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.5 | 6.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.5 | 0.9 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.5 | 1.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.5 | 0.5 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.5 | 3.7 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.5 | 1.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.5 | 0.5 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.5 | 0.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.5 | 0.5 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.5 | 0.5 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.5 | 2.7 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.5 | 2.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.5 | 0.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.5 | 5.5 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.5 | 1.4 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.5 | 0.5 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.5 | 2.7 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.5 | 1.4 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.5 | 2.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.4 | 0.9 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.4 | 0.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.4 | 1.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.4 | 1.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.4 | 4.9 | GO:0045116 | protein neddylation(GO:0045116) |
0.4 | 5.8 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.4 | 5.8 | GO:0032456 | endocytic recycling(GO:0032456) |
0.4 | 0.9 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.4 | 0.9 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.4 | 1.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.4 | 1.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.4 | 0.4 | GO:0006415 | translational termination(GO:0006415) |
0.4 | 2.6 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.4 | 4.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.4 | 2.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.4 | 0.9 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.4 | 0.4 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.4 | 1.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.4 | 1.7 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.4 | 0.4 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.4 | 0.8 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.4 | 2.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.4 | 3.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.4 | 1.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.4 | 2.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.4 | 0.4 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.4 | 1.2 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.4 | 2.5 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.4 | 1.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.4 | 2.9 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.4 | 2.0 | GO:0019068 | virion assembly(GO:0019068) |
0.4 | 1.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.4 | 2.0 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.4 | 0.4 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 1.2 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.4 | 0.8 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 1.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.4 | 2.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.4 | 2.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.4 | 3.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.4 | 1.2 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.4 | 1.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.4 | 1.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 12.4 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.4 | 9.6 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.4 | 0.8 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.4 | 1.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 1.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.4 | 3.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.4 | 1.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.4 | 1.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.4 | 1.6 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.4 | 2.7 | GO:0071800 | podosome assembly(GO:0071800) |
0.4 | 9.8 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.4 | 0.4 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.4 | 1.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.4 | 2.7 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.4 | 10.1 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.4 | 0.8 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.4 | 1.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.4 | 0.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 2.7 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.4 | 0.4 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.4 | 1.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.4 | 0.8 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.4 | 5.3 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.4 | 1.5 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 3.0 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.4 | 2.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.4 | 0.8 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.4 | 1.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 1.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 0.8 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.4 | 1.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 1.9 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.4 | 0.4 | GO:0050904 | diapedesis(GO:0050904) |
0.4 | 5.2 | GO:2000142 | regulation of DNA-templated transcription, initiation(GO:2000142) |
0.4 | 4.4 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.4 | 2.6 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
0.4 | 2.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.4 | 0.7 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.4 | 0.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.4 | 1.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 0.7 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.4 | 1.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.4 | 2.9 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.4 | 0.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 8.4 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.4 | 1.8 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.4 | 1.8 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.4 | 2.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.4 | 0.4 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.4 | 0.7 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.4 | 0.4 | GO:0045730 | respiratory burst(GO:0045730) |
0.4 | 1.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.4 | 1.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.4 | 0.4 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.4 | 0.4 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.3 | 1.0 | GO:0001832 | blastocyst growth(GO:0001832) |
0.3 | 0.7 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.3 | 0.7 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.3 | 2.8 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.3 | 1.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 1.4 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.3 | 0.3 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.3 | 2.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.3 | 0.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.3 | 1.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 2.0 | GO:0015809 | arginine transport(GO:0015809) |
0.3 | 1.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.3 | 3.0 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.3 | 2.3 | GO:0016447 | somatic recombination of immunoglobulin gene segments(GO:0016447) |
0.3 | 0.7 | GO:0033363 | secretory granule organization(GO:0033363) |
0.3 | 22.3 | GO:0007599 | hemostasis(GO:0007599) |
0.3 | 1.0 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 1.3 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 0.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 0.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 4.8 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.3 | 0.6 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.3 | 0.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.3 | 0.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.3 | 1.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.3 | 0.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.3 | 1.6 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.3 | 1.9 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.3 | 5.4 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.3 | 0.6 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.3 | 0.9 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.3 | 6.0 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.3 | 1.9 | GO:0072678 | T cell migration(GO:0072678) |
0.3 | 0.9 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.3 | 7.4 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.3 | 0.9 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.3 | 1.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 0.6 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.3 | 1.5 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.3 | 0.3 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.3 | 1.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.3 | 2.1 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 0.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 1.2 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.3 | 1.5 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.3 | 0.3 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.3 | 0.3 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.3 | 0.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 0.3 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.3 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.3 | 0.3 | GO:0050871 | positive regulation of B cell activation(GO:0050871) |
0.3 | 1.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 0.3 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.3 | 3.2 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.3 | 0.6 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.3 | 0.3 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.3 | 0.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 0.6 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.3 | 0.6 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.3 | 1.7 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.3 | 0.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 1.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 0.6 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.3 | 0.9 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.3 | 1.4 | GO:0000154 | rRNA modification(GO:0000154) |
0.3 | 0.3 | GO:0003032 | detection of oxygen(GO:0003032) |
0.3 | 1.4 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 0.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 0.6 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.3 | 0.3 | GO:0006266 | DNA ligation(GO:0006266) |
0.3 | 5.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 2.2 | GO:0070166 | enamel mineralization(GO:0070166) |
0.3 | 1.4 | GO:0007143 | female meiotic division(GO:0007143) |
0.3 | 0.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 1.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.3 | 0.3 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.3 | 0.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.3 | 0.6 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 1.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 0.3 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.3 | 0.6 | GO:0009112 | nucleobase metabolic process(GO:0009112) |
0.3 | 0.3 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.3 | 0.3 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.3 | 0.3 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.3 | 1.7 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 1.4 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.3 | 0.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.3 | 3.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.3 | 0.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 0.3 | GO:0080111 | DNA demethylation(GO:0080111) |
0.3 | 0.8 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.3 | 6.5 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.3 | 1.1 | GO:0042026 | protein refolding(GO:0042026) |
0.3 | 0.5 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 3.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 0.3 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.3 | 0.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 0.5 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.3 | 1.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 1.6 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.3 | 0.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.3 | 4.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.3 | 2.9 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.3 | 0.5 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 1.0 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.3 | 0.8 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.3 | 0.5 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.3 | 0.5 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.3 | 1.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.3 | 0.8 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.3 | 1.5 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.3 | 6.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.3 | 0.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.3 | 0.3 | GO:0060416 | response to growth hormone(GO:0060416) |
0.3 | 1.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 0.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 0.5 | GO:0035928 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.3 | 0.3 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.2 | 0.5 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 0.5 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.2 | 1.0 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.2 | 3.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 4.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.2 | 0.5 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 0.5 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 1.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.2 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.2 | 1.0 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 2.4 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 0.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 1.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 0.9 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.2 | 1.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 0.9 | GO:0051154 | negative regulation of striated muscle cell differentiation(GO:0051154) |
0.2 | 0.5 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 0.2 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.2 | 1.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 0.5 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.2 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.7 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 2.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 0.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 0.5 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 1.4 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.2 | 0.9 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.2 | 0.5 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.2 | 0.7 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 1.1 | GO:0048524 | positive regulation of viral process(GO:0048524) |
0.2 | 0.7 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.2 | 0.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.2 | 1.3 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.2 | 1.3 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.2 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 0.2 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.2 | 0.2 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.2 | 0.6 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.2 | 0.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.2 | 2.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 1.0 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 6.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.2 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.2 | 0.6 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 0.6 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.2 | 2.7 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.2 | 1.4 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.2 | 0.2 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.2 | 0.4 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 0.6 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 0.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 0.6 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.2 | 0.2 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.2 | 0.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 0.2 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.2 | 1.8 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.2 | 4.5 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.2 | 0.8 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 1.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 1.0 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.2 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 0.8 | GO:1903441 | receptor localization to nonmotile primary cilium(GO:0097500) protein localization to ciliary membrane(GO:1903441) |
0.2 | 0.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 1.1 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 4.6 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.5 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.2 | 0.4 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.2 | 0.4 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.2 | 1.4 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.2 | 3.0 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.2 | GO:0010226 | response to lithium ion(GO:0010226) |
0.2 | 2.8 | GO:0016575 | histone deacetylation(GO:0016575) |
0.2 | 7.4 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.2 | 1.6 | GO:0061515 | myeloid cell development(GO:0061515) |
0.2 | 2.6 | GO:0044728 | DNA methylation or demethylation(GO:0044728) |
0.2 | 0.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 0.2 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.2 | 0.3 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.2 | 0.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.2 | GO:0051181 | cofactor transport(GO:0051181) |
0.2 | 1.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.7 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.2 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 0.3 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 0.3 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.3 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 0.2 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.2 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 4.9 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.2 | 0.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 0.7 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.2 | 2.8 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
0.2 | 0.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.2 | 0.5 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.2 | 0.2 | GO:1903010 | regulation of bone development(GO:1903010) |
0.2 | 0.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 1.0 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 4.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.2 | GO:0060100 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.2 | 1.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.2 | 0.2 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.2 | 1.7 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.8 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.2 | 0.2 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.2 | 1.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 0.2 | GO:0015695 | organic cation transport(GO:0015695) |
0.2 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.8 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.2 | 0.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.2 | 0.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0044321 | response to leptin(GO:0044321) |
0.1 | 1.6 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 15.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 1.0 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.4 | GO:0097531 | mast cell migration(GO:0097531) |
0.1 | 2.1 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 0.1 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.1 | 1.0 | GO:0070918 | dsRNA fragmentation(GO:0031050) production of small RNA involved in gene silencing by RNA(GO:0070918) |
0.1 | 0.1 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 0.6 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.4 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.4 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.1 | 0.4 | GO:0051196 | regulation of coenzyme metabolic process(GO:0051196) |
0.1 | 1.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.7 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.3 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.3 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.1 | 11.1 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.1 | 0.6 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.1 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.3 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 0.3 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.3 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.1 | GO:0070741 | response to interleukin-6(GO:0070741) |
0.1 | 1.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 1.6 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 4.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.3 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.1 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.1 | 0.1 | GO:0044406 | adhesion of symbiont to host(GO:0044406) positive regulation of gap junction assembly(GO:1903598) |
0.1 | 1.0 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.6 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.1 | 0.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.8 | GO:0048599 | oocyte development(GO:0048599) |
0.1 | 0.7 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.1 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 0.1 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.1 | 0.6 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.1 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.1 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.1 | 0.2 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.1 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.1 | 1.3 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 3.0 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.1 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.1 | 0.1 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.6 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 3.1 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.1 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.1 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.1 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.6 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 2.8 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.2 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.4 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 2.0 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.1 | 0.3 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 6.5 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.3 | GO:0006971 | hypotonic response(GO:0006971) |
0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.1 | GO:0006304 | DNA modification(GO:0006304) |
0.1 | 0.4 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.1 | 1.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.2 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.4 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 0.1 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.1 | 0.6 | GO:0046364 | monosaccharide biosynthetic process(GO:0046364) |
0.1 | 1.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.3 | GO:0050779 | RNA destabilization(GO:0050779) |
0.1 | 0.2 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 2.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.7 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.1 | GO:1903430 | negative regulation of cell maturation(GO:1903430) |
0.1 | 0.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.2 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 1.3 | GO:0036503 | ERAD pathway(GO:0036503) |
0.1 | 0.7 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 1.0 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.9 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.1 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.5 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.3 | GO:0002707 | negative regulation of lymphocyte mediated immunity(GO:0002707) |
0.1 | 1.2 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.4 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.8 | GO:0007127 | meiosis I(GO:0007127) |
0.1 | 21.7 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.1 | 0.9 | GO:0046849 | bone remodeling(GO:0046849) |
0.1 | 0.2 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.1 | GO:0043476 | pigment accumulation(GO:0043476) |
0.1 | 0.3 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.1 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 0.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 1.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.1 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.1 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.2 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.1 | 2.0 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 0.1 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.1 | 0.9 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.1 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.1 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.1 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.1 | 0.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.2 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.1 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.1 | 0.3 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.1 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
0.0 | 0.1 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.0 | 0.0 | GO:0002001 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
0.0 | 0.1 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.0 | 0.1 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.1 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.0 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.0 | 0.0 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.0 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.0 | 0.0 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.0 | 0.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.2 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.2 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.0 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.0 | 0.7 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.0 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.0 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.0 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 1.0 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.1 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.0 | 2.5 | GO:0045087 | innate immune response(GO:0045087) |
0.0 | 0.0 | GO:0061009 | common bile duct development(GO:0061009) |
0.0 | 30.1 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.0 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.2 | GO:1903901 | negative regulation of viral life cycle(GO:1903901) |
0.0 | 0.1 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.0 | 0.0 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.0 | 0.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.0 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.0 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.0 | 0.0 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.1 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.0 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.7 | 94.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
9.9 | 49.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
7.8 | 23.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
5.8 | 29.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
4.7 | 14.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
4.6 | 27.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
4.5 | 22.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
4.0 | 15.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
3.8 | 15.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
3.6 | 14.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
3.3 | 10.0 | GO:0032127 | dense core granule membrane(GO:0032127) |
3.3 | 26.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
3.3 | 9.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
3.3 | 9.8 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
3.2 | 12.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
3.0 | 8.9 | GO:0042585 | germinal vesicle(GO:0042585) |
2.9 | 8.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.7 | 2.7 | GO:0015934 | large ribosomal subunit(GO:0015934) |
2.6 | 18.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
2.5 | 10.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
2.5 | 27.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
2.5 | 7.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
2.5 | 12.4 | GO:0005579 | membrane attack complex(GO:0005579) |
2.5 | 22.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
2.3 | 2.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
2.3 | 13.8 | GO:1990462 | omegasome(GO:1990462) |
2.2 | 6.6 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
2.1 | 10.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
2.1 | 6.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
2.1 | 8.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
2.0 | 8.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
2.0 | 10.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
2.0 | 12.2 | GO:0042629 | mast cell granule(GO:0042629) |
2.0 | 8.0 | GO:1990130 | Iml1 complex(GO:1990130) |
2.0 | 5.9 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
2.0 | 5.9 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.9 | 11.6 | GO:0031415 | NatA complex(GO:0031415) |
1.9 | 7.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.8 | 9.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.8 | 29.2 | GO:0000145 | exocyst(GO:0000145) |
1.8 | 18.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.8 | 5.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.8 | 14.3 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
1.8 | 53.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.8 | 5.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.7 | 17.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.7 | 1.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
1.7 | 20.4 | GO:0042581 | specific granule(GO:0042581) |
1.7 | 5.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.7 | 23.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.6 | 13.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.6 | 147.3 | GO:0072562 | blood microparticle(GO:0072562) |
1.6 | 4.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.6 | 6.3 | GO:0005642 | annulate lamellae(GO:0005642) |
1.5 | 9.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.5 | 4.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.5 | 4.6 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.5 | 3.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.5 | 4.5 | GO:0031523 | Myb complex(GO:0031523) |
1.5 | 7.3 | GO:0000796 | condensin complex(GO:0000796) |
1.5 | 29.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
1.5 | 42.1 | GO:0031941 | filamentous actin(GO:0031941) |
1.4 | 5.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.4 | 4.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.4 | 12.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
1.4 | 10.0 | GO:0005916 | fascia adherens(GO:0005916) |
1.4 | 9.9 | GO:0042382 | paraspeckles(GO:0042382) |
1.4 | 5.6 | GO:0035339 | SPOTS complex(GO:0035339) |
1.4 | 6.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.4 | 9.7 | GO:0031931 | TORC1 complex(GO:0031931) |
1.4 | 9.6 | GO:0045179 | apical cortex(GO:0045179) |
1.4 | 6.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.4 | 4.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.4 | 5.4 | GO:1990246 | uniplex complex(GO:1990246) |
1.4 | 5.4 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.3 | 12.0 | GO:0005869 | dynactin complex(GO:0005869) |
1.3 | 2.6 | GO:0005652 | nuclear lamina(GO:0005652) |
1.3 | 10.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.3 | 3.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.3 | 6.4 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.3 | 94.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.3 | 3.8 | GO:0097427 | microtubule bundle(GO:0097427) |
1.3 | 6.4 | GO:0030056 | hemidesmosome(GO:0030056) |
1.3 | 6.3 | GO:0097422 | tubular endosome(GO:0097422) |
1.3 | 3.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.3 | 17.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.2 | 7.4 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.2 | 9.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
1.2 | 7.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.2 | 9.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.2 | 3.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.2 | 12.1 | GO:0001772 | immunological synapse(GO:0001772) |
1.2 | 12.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.2 | 3.6 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.2 | 3.6 | GO:1990923 | PET complex(GO:1990923) |
1.2 | 28.4 | GO:0008305 | integrin complex(GO:0008305) |
1.2 | 7.1 | GO:0090544 | BAF-type complex(GO:0090544) |
1.2 | 4.7 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.2 | 5.9 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
1.2 | 4.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.1 | 4.5 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
1.1 | 47.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
1.1 | 1.1 | GO:0032432 | actin filament bundle(GO:0032432) |
1.1 | 25.7 | GO:0097228 | sperm principal piece(GO:0097228) |
1.1 | 4.4 | GO:0098536 | deuterosome(GO:0098536) |
1.1 | 48.4 | GO:0031985 | Golgi cisterna(GO:0031985) |
1.1 | 4.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.1 | 1.1 | GO:0070820 | tertiary granule(GO:0070820) |
1.1 | 3.2 | GO:0097413 | Lewy body(GO:0097413) |
1.1 | 5.3 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
1.0 | 17.8 | GO:0005795 | Golgi stack(GO:0005795) |
1.0 | 15.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.0 | 6.3 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.0 | 5.2 | GO:0005638 | lamin filament(GO:0005638) |
1.0 | 5.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
1.0 | 4.1 | GO:0070876 | SOSS complex(GO:0070876) |
1.0 | 1.0 | GO:0043219 | lateral loop(GO:0043219) |
1.0 | 9.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
1.0 | 5.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.0 | 4.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.0 | 6.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
1.0 | 27.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.0 | 4.0 | GO:0033269 | internode region of axon(GO:0033269) |
1.0 | 12.0 | GO:0031528 | microvillus membrane(GO:0031528) |
1.0 | 1.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.0 | 6.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.0 | 14.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.0 | 1.0 | GO:1990423 | RZZ complex(GO:1990423) |
1.0 | 7.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.0 | 1.9 | GO:0000805 | X chromosome(GO:0000805) |
1.0 | 1.9 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.0 | 3.8 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.0 | 2.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
1.0 | 2.9 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.9 | 7.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.9 | 5.7 | GO:0001739 | sex chromatin(GO:0001739) |
0.9 | 2.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.9 | 25.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.9 | 2.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.9 | 3.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.9 | 6.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.9 | 1.9 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.9 | 4.6 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.9 | 7.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.9 | 0.9 | GO:0000811 | GINS complex(GO:0000811) |
0.9 | 79.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.9 | 5.4 | GO:0090543 | Flemming body(GO:0090543) |
0.9 | 6.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.9 | 6.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.9 | 9.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.9 | 1.7 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.9 | 4.4 | GO:0061617 | MICOS complex(GO:0061617) |
0.9 | 17.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.9 | 12.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.9 | 2.6 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.9 | 2.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.9 | 7.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.9 | 6.0 | GO:0070652 | HAUS complex(GO:0070652) |
0.8 | 4.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.8 | 25.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.8 | 12.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.8 | 2.5 | GO:0008091 | spectrin(GO:0008091) |
0.8 | 6.6 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.8 | 10.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.8 | 10.7 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.8 | 13.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.8 | 85.6 | GO:0000793 | condensed chromosome(GO:0000793) |
0.8 | 7.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.8 | 4.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.8 | 3.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.8 | 20.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.8 | 2.4 | GO:0042555 | MCM complex(GO:0042555) |
0.8 | 3.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.8 | 1.6 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.8 | 22.0 | GO:0016592 | mediator complex(GO:0016592) |
0.8 | 4.7 | GO:0070187 | telosome(GO:0070187) |
0.8 | 0.8 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.8 | 4.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.8 | 5.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.8 | 2.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.8 | 39.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.8 | 3.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.8 | 12.2 | GO:0032982 | myosin filament(GO:0032982) |
0.8 | 0.8 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.8 | 2.3 | GO:0019815 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.8 | 24.3 | GO:0016459 | myosin complex(GO:0016459) |
0.8 | 21.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.7 | 27.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.7 | 5.2 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.7 | 4.4 | GO:0038201 | TOR complex(GO:0038201) |
0.7 | 5.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.7 | 1.5 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.7 | 1.5 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.7 | 13.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.7 | 13.8 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.7 | 2.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.7 | 2.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.7 | 5.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.7 | 4.8 | GO:0002102 | podosome(GO:0002102) |
0.7 | 2.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.7 | 88.5 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.7 | 4.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.7 | 8.2 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.7 | 2.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.7 | 2.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.7 | 2.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.7 | 6.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.7 | 4.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.7 | 0.7 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.7 | 31.8 | GO:0001726 | ruffle(GO:0001726) |
0.7 | 6.6 | GO:0032039 | integrator complex(GO:0032039) |
0.7 | 3.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.7 | 0.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.6 | 1.9 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.6 | 150.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.6 | 45.6 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.6 | 1.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.6 | 1.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.6 | 4.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.6 | 46.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.6 | 1.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.6 | 30.5 | GO:0000776 | kinetochore(GO:0000776) |
0.6 | 10.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.6 | 40.7 | GO:0010008 | endosome membrane(GO:0010008) |
0.6 | 1.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.6 | 4.0 | GO:0016235 | aggresome(GO:0016235) |
0.6 | 15.5 | GO:0015030 | Cajal body(GO:0015030) |
0.6 | 5.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.6 | 4.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.6 | 0.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.6 | 2.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.6 | 1.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.6 | 12.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.6 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.6 | 15.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.6 | 3.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.6 | 3.3 | GO:0034464 | BBSome(GO:0034464) |
0.6 | 2.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.5 | 1.6 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.5 | 1.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.5 | 1.1 | GO:0070469 | respiratory chain(GO:0070469) |
0.5 | 16.2 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.5 | 0.5 | GO:0071203 | WASH complex(GO:0071203) |
0.5 | 4.8 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.5 | 10.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.5 | 7.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.5 | 9.9 | GO:0005776 | autophagosome(GO:0005776) |
0.5 | 0.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.5 | 54.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.5 | 4.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.5 | 2.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.5 | 116.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.5 | 22.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.5 | 9.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.5 | 1.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.5 | 5.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 23.2 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.5 | 5.2 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.5 | 14.5 | GO:0042641 | actomyosin(GO:0042641) |
0.5 | 11.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.5 | 36.2 | GO:0005770 | late endosome(GO:0005770) |
0.5 | 0.5 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.5 | 4.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.5 | 6.0 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.5 | 0.9 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.5 | 0.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.5 | 2.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.5 | 5.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.5 | 4.5 | GO:0045120 | pronucleus(GO:0045120) |
0.5 | 2.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.4 | 17.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 1.3 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.4 | 1.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.4 | 17.2 | GO:0000922 | spindle pole(GO:0000922) |
0.4 | 1.8 | GO:0005688 | U6 snRNP(GO:0005688) |
0.4 | 12.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.4 | 8.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.4 | 3.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.4 | 0.4 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 11.4 | GO:0000502 | proteasome complex(GO:0000502) |
0.4 | 0.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 0.8 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.4 | 3.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.4 | 10.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.4 | 20.3 | GO:0005938 | cell cortex(GO:0005938) |
0.4 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.4 | 7.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 1.6 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.4 | 24.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.4 | 340.3 | GO:0005829 | cytosol(GO:0005829) |
0.4 | 4.6 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.4 | 0.8 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.4 | 0.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.4 | 13.8 | GO:0055029 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.4 | 6.7 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 1.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 1.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.4 | 46.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.4 | 26.1 | GO:0005925 | focal adhesion(GO:0005925) |
0.3 | 8.0 | GO:0005819 | spindle(GO:0005819) |
0.3 | 4.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 0.7 | GO:0030118 | clathrin coat(GO:0030118) |
0.3 | 3.7 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.3 | 5.0 | GO:0005657 | replication fork(GO:0005657) |
0.3 | 1.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 1.0 | GO:0044440 | endosomal part(GO:0044440) |
0.3 | 12.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 4.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 1.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 1.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 11.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.3 | 0.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 45.6 | GO:0005635 | nuclear envelope(GO:0005635) |
0.3 | 0.9 | GO:0001652 | granular component(GO:0001652) |
0.3 | 1.5 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.3 | 3.0 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.3 | 1.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 0.6 | GO:0071797 | LUBAC complex(GO:0071797) |
0.3 | 195.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.3 | 2.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 0.3 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.3 | 1.4 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.3 | 0.6 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.3 | 0.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 1.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 48.6 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.3 | 0.6 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.3 | 1.9 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.3 | 1.6 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.3 | 1.8 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 0.8 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.3 | 0.5 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.3 | 6.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 1.0 | GO:0000803 | sex chromosome(GO:0000803) XY body(GO:0001741) |
0.2 | 0.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 0.2 | GO:0043656 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.2 | 1.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 1.7 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 1.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 4.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 7.9 | GO:0005814 | centriole(GO:0005814) |
0.2 | 1.0 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 0.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 0.6 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 1.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 0.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 3.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 0.2 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 1.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 18.2 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.2 | 0.4 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 21.6 | GO:0005813 | centrosome(GO:0005813) |
0.2 | 0.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 1.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 0.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 199.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 110.4 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 12.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.5 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.2 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.8 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 1.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.2 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.8 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.1 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.0 | 2.5 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 2.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 6.9 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.0 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.2 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.4 | 49.8 | GO:0031720 | haptoglobin binding(GO:0031720) |
8.0 | 32.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
7.6 | 22.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
7.1 | 28.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
6.4 | 44.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
6.3 | 31.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
5.8 | 116.6 | GO:0030506 | ankyrin binding(GO:0030506) |
5.8 | 34.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
5.6 | 45.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
5.6 | 22.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
5.1 | 15.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
5.0 | 15.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
5.0 | 34.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
4.9 | 14.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
4.8 | 28.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
4.6 | 13.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
4.6 | 32.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
4.4 | 30.9 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
4.2 | 4.2 | GO:0030487 | inositol-4,5-bisphosphate 5-phosphatase activity(GO:0030487) |
4.1 | 20.7 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
4.0 | 12.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
4.0 | 7.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
3.9 | 19.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
3.9 | 11.7 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
3.9 | 15.5 | GO:0015265 | urea channel activity(GO:0015265) |
3.9 | 7.7 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
3.8 | 15.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
3.8 | 11.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
3.8 | 22.9 | GO:0004064 | arylesterase activity(GO:0004064) |
3.8 | 15.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
3.8 | 11.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
3.7 | 11.2 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
3.6 | 14.5 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
3.5 | 14.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
3.5 | 27.9 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
3.5 | 10.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
3.5 | 17.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
3.4 | 23.5 | GO:0046790 | virion binding(GO:0046790) |
3.2 | 16.2 | GO:0016151 | nickel cation binding(GO:0016151) |
3.2 | 12.9 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
3.2 | 41.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
3.2 | 12.7 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
3.1 | 12.5 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
3.1 | 21.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
3.1 | 9.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
2.9 | 8.8 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
2.9 | 17.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
2.9 | 17.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
2.8 | 11.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
2.8 | 5.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.8 | 11.2 | GO:0031433 | telethonin binding(GO:0031433) |
2.8 | 11.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
2.8 | 8.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
2.8 | 11.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
2.8 | 5.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
2.8 | 11.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
2.8 | 11.0 | GO:0009374 | biotin binding(GO:0009374) |
2.7 | 11.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
2.7 | 8.2 | GO:0004096 | catalase activity(GO:0004096) |
2.7 | 92.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
2.7 | 8.1 | GO:2001070 | starch binding(GO:2001070) |
2.7 | 10.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
2.6 | 37.0 | GO:0005521 | lamin binding(GO:0005521) |
2.6 | 10.5 | GO:0015232 | heme transporter activity(GO:0015232) |
2.6 | 7.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
2.6 | 7.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
2.6 | 7.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.5 | 10.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
2.5 | 7.4 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
2.4 | 12.0 | GO:0030274 | LIM domain binding(GO:0030274) |
2.4 | 9.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.4 | 35.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
2.4 | 4.7 | GO:0005123 | death receptor binding(GO:0005123) |
2.4 | 9.4 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
2.3 | 11.7 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
2.3 | 9.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
2.3 | 11.4 | GO:0043559 | insulin binding(GO:0043559) |
2.3 | 11.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
2.2 | 6.7 | GO:0035174 | histone serine kinase activity(GO:0035174) |
2.2 | 6.7 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
2.2 | 6.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
2.2 | 6.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
2.2 | 8.8 | GO:0030984 | kininogen binding(GO:0030984) |
2.2 | 6.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
2.2 | 11.0 | GO:0008199 | ferric iron binding(GO:0008199) |
2.2 | 6.5 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
2.2 | 6.5 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
2.2 | 2.2 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
2.2 | 10.8 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
2.1 | 31.8 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
2.1 | 40.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
2.1 | 73.7 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
2.1 | 18.9 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
2.1 | 10.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
2.1 | 2.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
2.1 | 8.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
2.1 | 18.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
2.0 | 18.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
2.0 | 5.9 | GO:0030911 | TPR domain binding(GO:0030911) |
1.9 | 17.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.9 | 13.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.9 | 5.7 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.9 | 11.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.9 | 9.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
1.9 | 3.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
1.9 | 5.7 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.9 | 5.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.9 | 9.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.9 | 5.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.8 | 18.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
1.8 | 3.6 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.8 | 19.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
1.8 | 5.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.8 | 8.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.8 | 37.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
1.8 | 31.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.8 | 5.3 | GO:0070840 | dynein complex binding(GO:0070840) |
1.8 | 14.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.7 | 7.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.7 | 15.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.7 | 5.2 | GO:0019767 | IgE receptor activity(GO:0019767) |
1.7 | 31.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
1.7 | 15.4 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
1.7 | 6.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.7 | 6.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.7 | 5.1 | GO:0050692 | DBD domain binding(GO:0050692) |
1.7 | 5.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.7 | 15.1 | GO:0039706 | co-receptor binding(GO:0039706) |
1.7 | 9.9 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
1.6 | 9.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.6 | 6.5 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
1.6 | 3.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.6 | 4.9 | GO:0071209 | U7 snRNA binding(GO:0071209) |
1.6 | 3.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
1.6 | 13.0 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
1.6 | 4.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.6 | 14.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.6 | 12.9 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.6 | 6.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.6 | 4.8 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.6 | 3.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.6 | 4.8 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.6 | 4.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.6 | 8.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.6 | 14.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.6 | 14.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.6 | 4.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.6 | 7.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.6 | 45.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.6 | 14.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.6 | 25.1 | GO:0001848 | complement binding(GO:0001848) |
1.6 | 11.0 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
1.6 | 1.6 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
1.5 | 1.5 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
1.5 | 7.6 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
1.5 | 6.0 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.5 | 4.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.5 | 8.9 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
1.5 | 7.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.5 | 25.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.5 | 10.3 | GO:0003896 | DNA primase activity(GO:0003896) |
1.5 | 7.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.5 | 4.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.5 | 11.6 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
1.5 | 5.8 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.4 | 10.1 | GO:0016208 | AMP binding(GO:0016208) |
1.4 | 8.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.4 | 50.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
1.4 | 5.8 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.4 | 8.6 | GO:0004630 | phospholipase D activity(GO:0004630) |
1.4 | 1.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.4 | 5.7 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.4 | 4.2 | GO:0000339 | RNA cap binding(GO:0000339) |
1.4 | 16.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.4 | 9.7 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
1.4 | 1.4 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
1.4 | 28.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.4 | 11.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.4 | 6.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.4 | 4.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.4 | 4.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.3 | 13.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
1.3 | 4.0 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.3 | 5.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.3 | 2.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.3 | 10.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.3 | 6.6 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.3 | 18.3 | GO:0008143 | poly(A) binding(GO:0008143) |
1.3 | 5.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.3 | 54.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
1.3 | 5.2 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
1.3 | 5.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
1.3 | 5.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.3 | 3.8 | GO:0019961 | interferon binding(GO:0019961) |
1.3 | 13.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.3 | 6.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.3 | 3.8 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
1.2 | 5.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
1.2 | 7.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.2 | 1.2 | GO:0043398 | HLH domain binding(GO:0043398) |
1.2 | 12.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.2 | 3.6 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.2 | 11.9 | GO:0004568 | chitinase activity(GO:0004568) |
1.2 | 4.7 | GO:0043515 | kinetochore binding(GO:0043515) |
1.2 | 10.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.2 | 4.7 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
1.2 | 24.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
1.2 | 11.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.2 | 16.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.2 | 1.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.2 | 8.1 | GO:0000150 | recombinase activity(GO:0000150) |
1.2 | 3.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.1 | 6.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.1 | 8.0 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
1.1 | 3.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.1 | 3.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.1 | 9.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
1.1 | 11.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.1 | 3.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.1 | 6.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.1 | 12.2 | GO:0010181 | FMN binding(GO:0010181) |
1.1 | 12.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
1.1 | 2.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.1 | 5.5 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
1.1 | 6.6 | GO:0016631 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
1.1 | 9.9 | GO:0030983 | mismatched DNA binding(GO:0030983) |
1.1 | 5.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.1 | 3.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.1 | 6.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
1.1 | 4.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.1 | 2.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.1 | 1.1 | GO:0032190 | acrosin binding(GO:0032190) |
1.1 | 1.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.1 | 30.6 | GO:0045502 | dynein binding(GO:0045502) |
1.0 | 2.1 | GO:0035877 | death effector domain binding(GO:0035877) |
1.0 | 9.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.0 | 9.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.0 | 4.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.0 | 12.4 | GO:0071949 | FAD binding(GO:0071949) |
1.0 | 3.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.0 | 3.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.0 | 3.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.0 | 1.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.0 | 3.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.0 | 5.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.0 | 19.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
1.0 | 2.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
1.0 | 3.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.0 | 3.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.0 | 9.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.0 | 8.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.0 | 7.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
1.0 | 6.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
1.0 | 8.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
1.0 | 2.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
1.0 | 2.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.0 | 14.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.0 | 4.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
1.0 | 4.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
1.0 | 4.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.0 | 3.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.0 | 2.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.0 | 39.8 | GO:0005507 | copper ion binding(GO:0005507) |
1.0 | 37.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.0 | 3.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.0 | 2.9 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
1.0 | 2.9 | GO:0031013 | troponin I binding(GO:0031013) |
1.0 | 3.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.0 | 18.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.0 | 11.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.0 | 6.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.0 | 3.9 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
1.0 | 3.8 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.0 | 11.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.9 | 2.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.9 | 8.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.9 | 64.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.9 | 1.9 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.9 | 0.9 | GO:0036033 | mediator complex binding(GO:0036033) |
0.9 | 1.8 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.9 | 5.5 | GO:0034046 | poly(G) binding(GO:0034046) |
0.9 | 10.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.9 | 1.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.9 | 4.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.9 | 18.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.9 | 13.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.9 | 2.7 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.9 | 6.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.9 | 4.5 | GO:0035173 | histone kinase activity(GO:0035173) |
0.9 | 6.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.9 | 8.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.9 | 5.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.9 | 8.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.9 | 18.5 | GO:0005537 | mannose binding(GO:0005537) |
0.9 | 7.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.9 | 1.8 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.9 | 0.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.9 | 0.9 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.9 | 0.9 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.9 | 0.9 | GO:0008142 | oxysterol binding(GO:0008142) |
0.9 | 0.9 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.9 | 9.6 | GO:0043176 | amine binding(GO:0043176) |
0.9 | 6.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.9 | 5.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.9 | 0.9 | GO:0045340 | mercury ion binding(GO:0045340) |
0.9 | 2.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.9 | 2.6 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.9 | 3.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.9 | 4.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.9 | 1.7 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.9 | 6.8 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.8 | 10.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.8 | 12.7 | GO:0043531 | ADP binding(GO:0043531) |
0.8 | 5.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.8 | 7.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.8 | 10.1 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.8 | 12.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.8 | 0.8 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.8 | 1.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.8 | 2.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.8 | 3.3 | GO:0034547 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.8 | 3.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.8 | 4.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.8 | 2.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.8 | 4.0 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.8 | 5.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.8 | 15.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.8 | 2.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.8 | 3.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.8 | 14.9 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.8 | 4.7 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.8 | 2.4 | GO:0008430 | selenium binding(GO:0008430) |
0.8 | 34.4 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.8 | 9.4 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.8 | 53.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.8 | 2.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.8 | 41.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.8 | 1.5 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.8 | 19.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.8 | 3.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.8 | 4.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.8 | 1.5 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.8 | 1.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.8 | 15.3 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.8 | 3.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.8 | 3.0 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.8 | 12.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.8 | 2.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.8 | 1.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.8 | 5.3 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.8 | 0.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.8 | 4.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.7 | 2.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.7 | 2.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.7 | 2.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.7 | 0.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.7 | 2.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.7 | 0.7 | GO:0034618 | arginine binding(GO:0034618) |
0.7 | 2.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.7 | 2.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.7 | 0.7 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.7 | 2.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.7 | 2.8 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.7 | 2.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.7 | 2.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.7 | 3.5 | GO:0005113 | patched binding(GO:0005113) |
0.7 | 2.1 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.7 | 9.8 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.7 | 7.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.7 | 2.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.7 | 2.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.7 | 6.3 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.7 | 5.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.7 | 0.7 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.7 | 6.9 | GO:0043274 | phospholipase binding(GO:0043274) |
0.7 | 6.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.7 | 0.7 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.7 | 4.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.7 | 2.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.7 | 3.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.7 | 59.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.7 | 21.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.7 | 3.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.7 | 0.7 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.7 | 3.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.7 | 4.6 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.7 | 1.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.7 | 2.6 | GO:0038100 | nodal binding(GO:0038100) |
0.7 | 12.4 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.7 | 1.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.7 | 0.7 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.6 | 15.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.6 | 6.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.6 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.6 | 3.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.6 | 1.9 | GO:0004359 | glutaminase activity(GO:0004359) |
0.6 | 5.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.6 | 2.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.6 | 1.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.6 | 4.4 | GO:0034891 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.6 | 28.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.6 | 6.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.6 | 3.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.6 | 0.6 | GO:0019808 | polyamine binding(GO:0019808) |
0.6 | 4.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.6 | 2.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.6 | 33.0 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.6 | 29.9 | GO:0051087 | chaperone binding(GO:0051087) |
0.6 | 1.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.6 | 1.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.6 | 16.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.6 | 1.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.6 | 1.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.6 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
0.6 | 3.5 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.6 | 1.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.6 | 5.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.6 | 15.8 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.6 | 43.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.6 | 13.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.6 | 2.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.6 | 1.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.6 | 14.2 | GO:0043022 | ribosome binding(GO:0043022) |
0.6 | 2.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.6 | 3.4 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.6 | 3.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.6 | 1.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.6 | 3.4 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.6 | 10.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.6 | 1.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.6 | 2.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.6 | 1.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.5 | 0.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.5 | 9.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.5 | 13.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.5 | 1.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.5 | 7.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.5 | 8.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.5 | 4.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.5 | 1.1 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.5 | 1.6 | GO:0034584 | piRNA binding(GO:0034584) |
0.5 | 0.5 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.5 | 1.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.5 | 1.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.5 | 0.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.5 | 1.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.5 | 2.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.5 | 6.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.5 | 4.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.5 | 2.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.5 | 2.6 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.5 | 4.6 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.5 | 1.0 | GO:0019862 | IgA binding(GO:0019862) |
0.5 | 4.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.5 | 1.0 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.5 | 14.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.5 | 4.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.5 | 3.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.5 | 12.0 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.5 | 2.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.5 | 0.5 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.5 | 9.4 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.5 | 1.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.5 | 2.9 | GO:0070402 | NADPH binding(GO:0070402) |
0.5 | 10.1 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.5 | 1.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.5 | 7.7 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.5 | 5.7 | GO:0052715 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.5 | 2.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.5 | 3.3 | GO:0090409 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.5 | 4.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.5 | 1.9 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.5 | 9.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.5 | 0.9 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.5 | 3.7 | GO:0015928 | fucosidase activity(GO:0015928) |
0.5 | 1.4 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.5 | 0.5 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.5 | 2.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.5 | 3.7 | GO:0001618 | virus receptor activity(GO:0001618) |
0.5 | 14.2 | GO:0070330 | aromatase activity(GO:0070330) |
0.5 | 2.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.5 | 1.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.5 | 1.4 | GO:0010858 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
0.5 | 1.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.5 | 2.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.4 | 0.9 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.4 | 4.4 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.4 | 1.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.4 | 2.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 3.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.4 | 0.9 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.4 | 31.0 | GO:0005506 | iron ion binding(GO:0005506) |
0.4 | 1.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 1.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.4 | 1.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.4 | 1.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.4 | 65.0 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.4 | 1.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 2.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.4 | 1.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.4 | 7.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 10.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.4 | 0.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.4 | 3.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.4 | 6.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 0.8 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.4 | 1.6 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.4 | 1.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.4 | 2.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 1.2 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 1.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.4 | 2.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.4 | 3.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 1.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.4 | 1.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 0.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 8.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.4 | 1.6 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.4 | 11.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.4 | 4.7 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.4 | 1.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 4.6 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.4 | 9.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.4 | 0.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.4 | 0.4 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.4 | 0.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.4 | 1.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.4 | 8.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.4 | 20.8 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.4 | 64.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.4 | 0.8 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.4 | 2.6 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.4 | 0.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 10.8 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.4 | 1.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.4 | 11.5 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.4 | 2.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.4 | 1.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.4 | 0.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.4 | 1.8 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.4 | 0.4 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.4 | 1.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 1.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.4 | 1.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.4 | 14.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.4 | 1.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.4 | 3.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.4 | 2.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.3 | 1.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 1.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 2.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.3 | 0.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.3 | 0.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 0.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 7.8 | GO:0019209 | kinase activator activity(GO:0019209) |
0.3 | 4.8 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.3 | 3.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 1.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 13.8 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.3 | 7.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.3 | 5.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 1.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 0.3 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.3 | 1.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.3 | 31.9 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.3 | 2.0 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.3 | 4.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.3 | 13.7 | GO:0019003 | GDP binding(GO:0019003) |
0.3 | 0.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.3 | 9.2 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.3 | 0.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.3 | 9.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.3 | 3.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 0.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 0.9 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.3 | 1.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 0.9 | GO:1990405 | protein antigen binding(GO:1990405) |
0.3 | 7.7 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.3 | 7.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 4.9 | GO:0020037 | heme binding(GO:0020037) |
0.3 | 2.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.3 | 0.9 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 0.6 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.3 | 5.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.3 | 14.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 1.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.3 | 0.9 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.3 | 2.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 2.1 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.3 | 1.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 0.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 9.3 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.3 | 15.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.3 | 1.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 0.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 0.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 3.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 0.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 4.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 2.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.3 | 3.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.3 | 2.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.3 | 0.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.3 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 4.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.3 | 0.5 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.3 | 5.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.3 | 20.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.3 | 1.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.3 | 1.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 0.3 | GO:0015923 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
0.3 | 5.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.3 | 3.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.3 | 0.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 1.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 1.0 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 1.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 3.3 | GO:0051287 | NAD binding(GO:0051287) |
0.3 | 3.3 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.3 | 1.3 | GO:0017069 | snRNA binding(GO:0017069) |
0.3 | 8.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 0.5 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.3 | 3.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 0.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 1.5 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.2 | 2.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 1.5 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.2 | 0.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 0.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 1.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 2.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 1.0 | GO:0009975 | cyclase activity(GO:0009975) |
0.2 | 1.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 0.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 34.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 1.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.2 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.2 | 1.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 8.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 19.5 | GO:0005550 | pheromone binding(GO:0005550) |
0.2 | 0.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 12.3 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 2.3 | GO:0047617 | palmitoyl-CoA hydrolase activity(GO:0016290) acyl-CoA hydrolase activity(GO:0047617) |
0.2 | 0.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 0.6 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 1.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 0.4 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 0.2 | GO:0015926 | glucosidase activity(GO:0015926) |
0.2 | 0.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 1.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 1.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 0.6 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.2 | 2.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 0.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 2.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 2.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 3.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 0.4 | GO:0048030 | disaccharide binding(GO:0048030) |
0.2 | 0.4 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 2.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 0.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 1.2 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.5 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 4.4 | GO:0002020 | protease binding(GO:0002020) |
0.2 | 6.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 11.6 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.2 | 0.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 0.8 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 1.5 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.2 | 0.8 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 7.5 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.2 | 0.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 0.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 4.6 | GO:0005496 | steroid binding(GO:0005496) |
0.2 | 1.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.5 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 4.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 2.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 2.2 | GO:0043883 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.7 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.1 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 0.4 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.1 | 0.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 1.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 1.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 30.0 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 1.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 14.8 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
0.1 | 0.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 4.7 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 1.7 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.2 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.1 | 1.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 4.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 16.8 | GO:0032561 | guanyl ribonucleotide binding(GO:0032561) |
0.1 | 0.6 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.5 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.8 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 1.1 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 9.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 40.7 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 2.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.1 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.1 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 1.6 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 2.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.7 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.1 | 1.1 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.1 | 1.6 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 1.9 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.2 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 1.9 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.9 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.2 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 0.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.4 | GO:0015296 | anion:cation symporter activity(GO:0015296) |
0.0 | 0.3 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 45.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 0.4 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.4 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.0 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.2 | GO:0070008 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.0 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 8.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
4.0 | 55.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
2.4 | 71.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
2.1 | 66.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
2.0 | 7.9 | PID FOXO PATHWAY | FoxO family signaling |
1.9 | 42.5 | PID EPO PATHWAY | EPO signaling pathway |
1.9 | 48.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.8 | 63.3 | PID RHOA PATHWAY | RhoA signaling pathway |
1.8 | 50.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.8 | 14.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.7 | 70.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.7 | 64.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.7 | 14.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.6 | 14.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.6 | 14.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.6 | 68.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.4 | 7.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.4 | 29.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.3 | 5.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.3 | 21.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
1.3 | 20.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.3 | 27.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
1.2 | 16.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.2 | 11.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.2 | 13.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.2 | 3.6 | PID IGF1 PATHWAY | IGF1 pathway |
1.2 | 26.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.2 | 3.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
1.2 | 33.4 | PID PLK1 PATHWAY | PLK1 signaling events |
1.1 | 18.2 | PID AURORA A PATHWAY | Aurora A signaling |
1.1 | 9.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.1 | 48.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
1.1 | 3.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.1 | 6.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.1 | 21.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.1 | 26.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.0 | 6.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.0 | 14.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.0 | 7.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.0 | 89.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
1.0 | 7.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.0 | 1.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.9 | 15.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.9 | 33.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.9 | 4.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.9 | 27.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.9 | 10.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.9 | 0.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.9 | 12.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.9 | 23.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.8 | 10.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.8 | 20.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.8 | 12.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.8 | 24.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.8 | 1.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.8 | 9.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.8 | 11.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.8 | 4.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.8 | 5.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.8 | 27.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.7 | 12.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.7 | 22.3 | PID P73PATHWAY | p73 transcription factor network |
0.7 | 2.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.7 | 15.3 | PID FGF PATHWAY | FGF signaling pathway |
0.7 | 8.9 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.7 | 2.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.7 | 1.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.7 | 12.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.7 | 8.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.6 | 1.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.6 | 5.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.6 | 4.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.6 | 4.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.6 | 12.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.6 | 1.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.6 | 2.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.6 | 5.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.5 | 4.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.5 | 19.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.5 | 0.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.5 | 6.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.5 | 8.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.5 | 10.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.5 | 5.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.5 | 19.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.5 | 9.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.5 | 1.9 | ST GAQ PATHWAY | G alpha q Pathway |
0.5 | 7.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.5 | 6.0 | PID ATM PATHWAY | ATM pathway |
0.4 | 0.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 11.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 7.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.4 | 3.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.4 | 2.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 1.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.4 | 0.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 1.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 4.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.3 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 9.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 5.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 5.3 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 2.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 0.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 1.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 4.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 1.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 0.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 0.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 0.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 2.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 1.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 0.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 31.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 2.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 1.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.0 | 72.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
5.0 | 44.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
4.8 | 67.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
4.4 | 52.6 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
3.7 | 36.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
3.4 | 60.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
3.0 | 33.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
3.0 | 30.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
2.8 | 56.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
2.7 | 82.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
2.4 | 31.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
2.3 | 22.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
2.3 | 4.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
2.2 | 4.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
2.0 | 66.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
2.0 | 15.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
2.0 | 5.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
1.9 | 25.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.9 | 26.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
1.9 | 9.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.8 | 31.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.7 | 36.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.7 | 53.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
1.7 | 27.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.7 | 5.1 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
1.7 | 6.8 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.6 | 75.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.6 | 4.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.6 | 24.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.6 | 43.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.6 | 24.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.6 | 16.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.6 | 8.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.6 | 14.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.6 | 10.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.5 | 4.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.5 | 29.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.5 | 54.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.5 | 152.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.5 | 30.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.5 | 19.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.4 | 25.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
1.4 | 18.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.4 | 12.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
1.4 | 21.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.4 | 8.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
1.4 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.4 | 20.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.3 | 10.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.3 | 5.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
1.3 | 1.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.3 | 7.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.3 | 14.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.3 | 8.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.3 | 11.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.3 | 11.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
1.2 | 9.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.2 | 25.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.2 | 17.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.2 | 28.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
1.1 | 33.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
1.1 | 30.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
1.1 | 35.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.1 | 6.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.0 | 7.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.0 | 11.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.0 | 9.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.0 | 11.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.0 | 16.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.0 | 9.6 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.9 | 10.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.9 | 29.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.9 | 2.8 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.9 | 23.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.9 | 7.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.9 | 14.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.9 | 4.5 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.9 | 7.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.9 | 19.2 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.9 | 7.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.9 | 16.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.9 | 6.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.9 | 18.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.8 | 16.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.8 | 15.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.8 | 19.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.8 | 9.9 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.8 | 20.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.8 | 8.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.8 | 7.9 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.8 | 5.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.8 | 8.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.7 | 2.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.7 | 18.9 | REACTOME TRANSLATION | Genes involved in Translation |
0.7 | 3.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.7 | 10.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.7 | 0.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.7 | 61.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.7 | 11.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.7 | 9.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.7 | 2.8 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.7 | 25.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.7 | 4.7 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.7 | 10.7 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.7 | 14.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.6 | 5.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.6 | 27.5 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.6 | 33.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.6 | 5.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.6 | 5.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.6 | 13.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.6 | 1.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.6 | 14.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.6 | 0.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.6 | 12.8 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.6 | 6.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.6 | 7.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.6 | 14.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.6 | 4.7 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.6 | 8.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.6 | 2.3 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.6 | 6.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.6 | 4.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.6 | 15.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.6 | 3.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.6 | 23.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.6 | 48.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.6 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.6 | 16.3 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.6 | 42.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.5 | 6.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.5 | 14.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.5 | 5.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.5 | 33.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.5 | 24.0 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.5 | 5.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.5 | 4.6 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.5 | 5.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 0.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.5 | 3.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.5 | 9.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.5 | 12.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.5 | 6.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.5 | 3.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.5 | 2.4 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
0.5 | 7.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.5 | 3.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.5 | 0.5 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.4 | 5.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.4 | 0.9 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.4 | 0.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.4 | 12.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.4 | 2.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 5.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.4 | 2.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.4 | 2.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 2.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.4 | 2.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.4 | 23.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.4 | 0.4 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.4 | 5.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 31.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.4 | 4.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.4 | 6.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.4 | 1.9 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.4 | 3.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 1.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.4 | 3.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.4 | 0.4 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.4 | 8.8 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.4 | 7.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.3 | 4.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 3.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 2.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 0.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.3 | 14.7 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.3 | 2.5 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 7.6 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.3 | 12.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 0.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 8.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.3 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 0.3 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.3 | 18.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 1.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 4.1 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.3 | 5.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 6.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.3 | 2.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 1.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 4.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 1.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 1.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 1.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 29.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.3 | 0.3 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 2.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 0.7 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 3.5 | REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT | Genes involved in SLC-mediated transmembrane transport |
0.2 | 1.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 2.4 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.2 | 3.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 0.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 1.3 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.2 | 8.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 2.0 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 2.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 6.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 0.8 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.2 | 0.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 1.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 0.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 2.8 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.1 | 0.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.8 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.5 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 3.1 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 0.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.2 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 1.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.1 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |